Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3029493	b-hhv6nh	— (—)	373	1103	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

L04AD Calcineurin inhibitors

212

100.84

307.65

3.9

3.7

—

ILD medications: immunosuppressive drugs

258

31.76

307.65

3.7

1.2

—

Transplanted organ and tissue status

214

204.70

307.65

4.2

1.2

—

ILD medications

257

18.04

207.00

3.8

1.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

239

19.30

201.72

3.6

1.1

—

L04AA Selective immunosuppressants

134

25.12

191.26

4.0

3.0

—

ILD medications: azathioprine

105

62.65

189.77

4.6

1.0

—

First line medication for Crohn's disease

245

15.73

187.43

3.8

1.4

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

235

116

12.83

184.02

3.7

1.2

—

Nephropathy related operations

112

35.74

178.70

3.5

—

Dialysis, with operation codes

110

37.39

177.72

3.2

3.8

—

Fever of other and unknown origin

154

17.39

171.70

2.9

2.0

—

Azathioprine

105

28.02

155.63

4.6

3.2

—

Kidney transplant status

37.99

147.04

4.1

4.4

—

Molar incisor enamel hypoplasia, with caries

64.56

125.25

5.7

2.9

—

Dental caries

103

18.46

124.69

3.6

1.2

—

L04AX Other immunosuppressants

145

155

9.39

121.80

4.2

2.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

18.77

120.34

3.0

3.3

—

Second line medication for Crohn's disease

147

163

9.04

120.02

4.3

2.0

—

Liquid cancers

100

17.96

119.82

3.0

3.4

—

Explicit Sepsis, including avohilmo

114

12.96

112.52

3.8

3.3

—

Explicit Sepsis

113

12.91

111.58

3.8

3.3

—

Renal failure

117

12.66

109.84

3.1

2.7

—

Chronic kidney disease

16.97

109.65

3.4

3.2

—

Hypoplasia of dental enamel

27.23

106.85

5.7

5.5

—

Bacterial infection, other or unspecified

113

12.75

105.93

3.2

3.0

—

Septicaemia

110

12.28

105.51

3.8

3.9

—

Implicit viral Sepsis

24.83

105.16

3.3

3.2

—

Other septicaemia, including avohilmo

102

13.35

104.47

3.8

3.9

—

Other septicaemia

101

13.47

104.25

3.9

—

Viral Sepsis

24.03

103.88

3.3

3.1

—

Liquid cancers, including Hilmo

103

13.82

103.60

3.0

3.5

—

Other problems related to primary support group, including family circumstances

16.71

103.34

5.7

3.5

—

GASTRO-related operations

122

24.52

101.86

3.6

1.6

—

Any gastric operation

122

24.52

101.86

3.6

1.6

—

Diseases of liver

13.85

98.74

2.4

2.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

178

175

6.87

96.50

3.2

2.6

—

Inflammatory bowel disease treatment related agents

193

152

7.05

96.46

3.4

2.4

—

Other bacterial diseases

173

161

7.13

95.85

3.3

2.7

—

Implicit viral Sepsis, including avohilmo

16.85

94.97

3.1

3.2

—

Caries of dentine

17.02

93.37

3.1

1.1

—

Molar incisor enamel hypoplasia

14.64

92.04

6.0

4.8

—

Bacterial infection, other or unspecified, including avohilmo

116

9.72

90.42

3.1

2.9

—

Hypoplasia of dental enamel , including avohilmo

14.80

88.58

6.0

5.1

—

Other bacterial diseases, including avohilmo

176

170

6.47

87.40

3.3

2.8

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

9.94

85.36

5.4

2.5

—

Other diseases of blood and blood-forming organs, wide

15.42

82.77

3.1

3.2

—

All chronic kidney diseases

120

119

8.06

80.51

3.1

2.9

—

Gingival hyperplasia

24.67

80.09

5.2

4.8

—

Anaemias

22.83

77.59

4.2

2.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

130

124

7.27

75.00

2.6

—

Implicit Sepsis, including avohilmo

126

124

7.27

73.80

2.7

2.5

—

Implicit Sepsis

118

113

7.70

73.51

2.8

2.6

—

Bacterial Sepsis

11.46

72.31

2.9

—

All kidney diseases

159

191

5.58

71.47

3.2

2.8

—

Influenza and pneumonia

166

189

5.43

69.88

2.7

3.0

—

Implicit bacterial Sepsis

12.80

69.29

2.8

2.4

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

133

138

6.51

69.13

2.7

—

Renal tubulo-interstitial diseases

142

180

5.79

68.80

3.1

2.6

—

Implicit bacterial Sepsis, including avohilmo

11.95

68.13

2.7

2.3

—

Care involving dialysis

23.66

68.11

4.1

3.8

—

Agranulocytosis

23.56

68.07

3.4

4.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

118

8.03

66.94

2.6

2.1

—

118

8.03

66.94

2.6

2.1

—

Cardiovascular diseases (excluding rheumatic etc)

138

120

6.59

66.63

3.9

3.3

—

Acute renal failure

18.66

65.62

2.9

2.6

—

Other viral diseases

101

150

6.75

64.27

4.4

3.3

—

Other viral diseases, including avohilmo

107

176

6.04

61.11

3.9

3.0

—

General symptoms and signs

125

7.37

61.10

2.3

1.9

—

Viral infections characterized by skin and mucous membrane lesions

100

161

6.23

59.09

3.6

3.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

118

195

5.41

57.90

3.7

2.4

—

Antihypertensive medication - note that there are other indications

128

107

6.26

56.52

4.5

2.8

—

Cardiovascular diseases

126

108

6.20

55.67

4.0

3.5

—

Pneumonias (Asthma/COPD co-morbidities)

148

204

4.74

55.66

2.8

3.0

—

Dialysis

20.06

55.62

4.7

4.5

—

Hypertensive diseases (excluding secondary)

8.47

54.63

3.9

2.8

—

Certain infectious and parasitic diseases

106

7.93

54.53

3.3

1.6

—

All influenza

9.44

53.23

3.5

4.1

—

Intestinal infectious diseases

135

215

4.67

52.61

3.5

2.3

—

Persons encountering health services for specific procedures and health care

153

199

4.54

52.56

3.1

2.9

—

Pneumonia, organism unspecified

130

181

4.93

52.08

2.6

3.1

—

All pneumoniae

148

215

4.48

52.05

2.6

3.0

—

Nausea and vomiting

8.06

51.70

3.6

3.9

—

Aplastic and other anaemias

7.35

48.59

3.1

2.7

—

Examination and observation for other reasons

9.76

47.94

2.3

1.3

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

142

221

4.28

47.90

2.7

3.0

—

Viral warts

14.46

47.63

4.2

—

Gastrointestinal diseases

12.55

46.49

4.0

1.2

—

Any reimbursement code in KELA

12.11

45.75

3.6

1.0

—

Other viral diseases, not elsewhere classified

108

6.69

45.50

5.3

3.9

—

Glomerular diseases

9.29

40.91

3.8

3.4

—

Acute upper respiratory infections of multiple and unspecified sites

141

5.02

40.78

3.4

2.1

—

Coagulation defects, purpura and other haemorrhagic conditions

8.97

40.65

2.3

4.5

—

Bronchitis

114

148

4.62

40.35

3.0

1.8

—

Other viral diseases, not elsewhere classified, including avohilmo

145

5.37

39.50

4.6

3.4

—

Infections, IBD-co-morbidities

12.99

38.92

2.4

4.4

—

Viral and other specified intestinal infections

6.92

38.88

4.2

3.5

—

Heart failure, not strict

129

4.96

38.08

2.8

2.4

—

Glomerulonephritis

11.57

37.81

3.9

—

Hypertensive diseases

107

132

4.58

36.51

3.6

2.3

—

Hypertension

107

132

4.58

36.50

3.6

2.3

—

Purpura and other haemorrhagic conditions

10.89

36.40

2.0

5.5

—

Viral and other specified intestinal infections, including avohilmo

105

5.88

35.35

4.0

3.1

—

Other medical care

6.63

35.20

2.2

3.1

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

12.13

35.00

2.9

1.9

—

Malignant neoplasm

106

143

4.35

34.70

3.4

2.7

—

Medical observation and evaluation for suspected diseases and conditions

7.79

34.59

2.7

1.3

—

Malignant neoplasm

105

141

4.37

34.55

3.4

2.8

—

Malignant neoplasm, including Hilmo

107

147

4.24

33.99

3.4

2.8

—

Other heart diseases

5.51

33.93

3.1

3.8

—

Any event in cancer register

108

151

4.18

33.74

3.0

2.8

—

Other anaemias

6.48

33.66

3.2

2.6

—

Bacterial pneumoniae

7.06

33.52

2.6

3.1

—

Malignant neoplasm, wide definition

107

149

4.18

33.43

3.4

2.8

—

Nephrotic syndrome

13.12

33.25

4.1

4.9

—

Neoplasms

115

149

4.05

33.10

4.0

3.1

—

Failure and rejection of transplanted organs and tissues

52.46

32.99

3.7

7.0

—

Other and unspecified anaemias

6.38

32.64

3.2

2.6

—

Complications of medical and surgical care

162

4.50

32.45

3.0

2.1

—

Other congenital malformations of the digestive system

7.73

32.06

5.3

5.5

—

COPD/asthma/ILD related infections

5.07

31.30

2.9

2.1

—

COPD/asthma related infections

5.07

31.30

2.9

2.1

—

Metabolic disorders

111

177

3.76

30.77

2.6

—

Bacterial pneumonia, not elsewhere classified

6.95

30.58

2.5

3.2

—

101

120

4.27

30.48

2.8

1.9

—

Oral corticosteroids

129

4.27

30.26

1.6

1.9

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

111

250

3.46

29.87

3.2

2.8

—

Covid-19 confirmed case

5.75

29.59

2.7

3.0

—

All influenza (not pneumonia)

9.04

29.44

3.3

3.9

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

109

195

3.59

29.02

3.1

2.4

—

Bacterial pneumonia (organism specified)

100

5.35

28.94

2.6

2.8

—

Complications of surgical and medical care, not elsewhere classified

100

179

3.73

28.49

3.0

2.3

—

Cholangitis (primary sclerosing, PSC)

26.35

28.38

4.2

3.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

136

4.69

28.24

3.3

2.1

—

Intestinal infectious diseases, including avohilmo, including avohilmo

118

191

3.44

28.17

2.8

2.4

—

Secondary hypertension

25.85

28.12

4.1

3.7

—

Other reaction to severe stress, and adjustment disorders

111

5.14

27.71

4.4

2.3

—

Non-Hodgkin lymphoma, all, including Hilmo

28.63

27.55

1.9

2.5

—

Other disorders of fluid, electrolyte and acid-base balance

7.26

26.72

2.8

2.7

—

Any death

4.86

26.48

2.0

2.1

—

Other congenital malformations of the digestive system, including avohilmo

6.34

26.29

5.4

—

Provisional assignment of new diseases of uncertain etiology

167

4.16

26.28

2.8

2.7

—

Codes for special purposes

167

4.16

26.27

2.8

2.7

—

Other metabolic disorders

10.40

26.22

1.8

3.3

—

General examination and investigation of persons without complaint and reported diagnosis

6.61

25.96

3.8

1.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

6.57

25.92

3.6

1.3

—

Extracorporeal dialysis

22.82

25.21

4.1

3.7

—

Symptoms and signs involving the digestive system and abdomen

109

158

3.46

25.21

3.3

2.9

—

Acute tubulo-interstitial nephritis

135

4.25

25.01

3.8

2.8

—

Viral pneumonia

9.71

24.98

2.5

3.7

—

Acute upper respiratory infections

150

3.68

24.80

3.1

2.1

—

Zoster [herpes zoster]

10.03

24.69

3.3

1.8

—

Primary Sclerosing Cholangitis, IBD and UDCA required

30.11

24.21

3.7

3.5

—

Other acute lower respiratory infections

200

3.67

24.07

3.2

3.3

—

Certain disorders involving the immune mechanism

6.42

23.86

6.4

3.4

—

Headache

5.09

23.72

3.2

1.9

—

Enlarged lymph nodes

18.49

22.97

3.0

3.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

6.18

22.79

2.6

2.7

—

Anomalies of dental arch relationship, including avohilmo

4.93

22.44

4.4

3.6

—

Viral warts, including avohilmo

5.25

22.42

4.2

3.7

—

Disorders of gallbladder, biliary tract and pancreas

154

3.52

22.41

3.8

1.8

—

Unspecified jaundice

45.50

22.37

3.6

3.8

—

Other diseases of biliary tract

24.01

22.13

3.7

2.5

—

Acute suppurative otitis media

118

4.35

21.53

3.9

3.2

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

129

4.24

21.39

4.3

4.5

—

Pain, not elsewhere classified

8.25

21.35

2.3

2.6

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

125

4.29

21.32

4.4

4.6

—

Speech and linguistic disorders, excluding more controls

5.73

21.31

4.8

4.2

—

Reimbursement for rheumatic diseases

159

3.88

21.26

3.6

2.6

—

Congenital malformation of biliary tract

32.99

20.90

6.2

3.9

—

Cytomegaloviral disease

38.16

20.86

2.6

5.7

—

Cytomegaloviral disease, including avohilmo

38.15

20.85

2.6

5.7

—

Acute bronchitis

143

3.98

20.56

3.0

3.7

—

Fibrosis and cirrhosis of liver

30.23

20.54

3.1

2.8

—

Other/unspecified cytomegaloviral diseases

33.60

20.30

2.6

6.1

—

Care involving use of rehabilitation procedures

171

3.58

20.23

3.4

3.0

—

Crossbite

4.65

20.17

5.1

4.9

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

138

3.87

20.02

4.3

4.0

—

Mycoses

5.35

19.90

2.5

3.1

—

Endocrine, nutritional and metabolic diseases

147

3.23

19.87

3.5

3.2

—

Congenital malformations of gallbladder, bile ducts and liver

23.19

19.81

6.3

3.9

—

Disorders of psychological development

114

4.26

19.70

4.6

4.4

—

Pulmonary heart disease, diseases of pulmonary circulation

6.41

19.60

1.7

2.0

—

Oxycodone

5.56

19.58

1.5

1.3

—

Erosion of teeth , including avohilmo

105

4.49

19.55

4.9

2.8

—

Other inflammatory liver diseases

40.37

19.49

1.9

1.7

—

Thrombocytopenia, unspecified

19.50

19.48

2.3

5.7

—

Cytomegalovirus infection, IBD co-morbidity

26.73

19.20

2.6

5.2

—

Other dialysis

23.00

19.11

4.8

3.9

—

Nonsuppurative otitis media

4.35

18.75

3.9

3.5

—

7.84

18.27

2.4

2.6

—

Genitourinary diseases

123

3.35

18.25

4.8

3.1

—

Autoimmune hepatitis, wide definition

44.43

18.25

2.0

5.8

—

Nutritional anaemias

126

3.94

18.04

3.1

3.0

—

Other diseases of the digestive system

5.01

18.03

4.3

3.3

—

Other pulmonary diagnosis

4.52

17.77

3.1

1.9

—

Hypoplasia of dental enamel, prenatal

27.45

17.60

6.7

4.6

—

Non-follicular lymphoma

20.96

17.27

1.7

2.6

—

Solid cancers

122

3.41

17.26

2.5

2.4

—

Convulsions, not elsewhere classified

6.24

17.23

3.3

2.7

—

Suppurative and unspecified otitis media

132

3.70

17.12

4.0

3.0

—

Iron deficiency anaemia

114

4.05

17.08

3.2

3.1

—

Other disorders starting during childhood or adolecense, excluding more controls

5.38

17.04

5.7

4.1

—

Diseases of the digestive system

148

3.63

16.88

3.6

3.1

—

Otitis media, unspecified

4.82

16.75

4.1

—

Infections of the skin and subcutaneous tissue

252

2.93

16.61

4.1

2.7

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

23.69

16.51

4.6

3.2

—

Heart failure and antihypertensive medication

6.51

16.50

2.5

1.9

—

Excluding asthma or asthma-COPD overlap

4.36

16.47

3.2

1.9

—

Lymphoid leukaemia

13.48

16.46

4.8

5.0

—

Oedema, not elsewhere classified

7.33

16.44

2.2

1.8

—

Congenital malformations of the urinary system, including avohilmo

6.14

16.39

3.7

5.9

—

Hernia of abdominal wall, postoperative

39.74

16.25

1.8

2.0

—

Certain infectious and parasitic diseases, including avohilmo

4.72

16.25

3.8

1.6

—

Unspecified kidney failure

30.12

16.09

2.6

3.7

—

Disorders resulting from impaired renal tubular function

24.79

16.02

4.2

3.8

—

Drug-induced neutropenia

24.61

15.99

2.1

2.4

—

GI-bleeding

4.68

15.82

4.4

3.4

—

Speech and linguistic disorders

114

3.90

15.71

4.7

4.6

—

Specific development disorders of scholastic skills

5.20

15.63

6.1

4.7

—

Solid cancers, including Hilmo

127

3.21

15.57

2.5

2.4

—

COPD differential diagnosis

4.20

15.55

3.2

1.9

—

ILD differential diagnosis

4.20

15.55

3.2

1.9

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

198

2.66

15.53

2.6

2.7

—

Other disorders of kidney and ureter

11.72

15.51

3.5

2.9

—

Abdominal and pelvic pain

158

2.83

15.32

3.4

2.9

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

16.30

15.27

8.5

5.9

—

Other disorders involving the immune mechanism, not elsewhere classified

16.28

15.26

8.5

5.9

—

Congenital malformations of the urinary system

5.92

15.25

3.8

5.9

—

Other heart diseases, wide

231

2.57

15.02

2.8

3.0

—

Bacterial intestinal infections, IBD co-morbidities

6.78

14.84

1.8

3.4

—

Cardiomyopathy

6.78

14.83

3.1

3.2

—

Cirrhosis of liver, NAS

31.92

14.80

2.6

3.2

—

Persons with potential health hazards related to communicable diseases

197

3.07

14.74

4.5

3.5

—

Symptoms and signs concerning food and fluid intake

16.46

14.72

4.7

4.3

—

Malaise and fatigue

4.75

14.46

3.3

2.3

—

Implicit fungal Sepsis, including avohilmo

36.19

14.43

3.3

3.0

—

Acute pharyngitis

5.23

14.42

3.2

3.5

—

Crowding of teeth, including avohilmo

4.02

14.37

4.6

4.9

—

Disorders of other endocrine glands

199

3.02

14.31

4.1

3.5

—

Other bacterial intestinal infections, including avohilmo

5.96

14.30

1.7

2.3

—

Abnormal findings on examination of blood, without diagnosis

114

3.65

14.24

3.1

2.9

—

Secondary and unspecified malignant neoplasm of lymph nodes

19.19

14.21

1.4

4.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

19.18

14.21

2.9

2.7

—

Nonsuppurative otitis media, including avohilmo

113

3.60

14.06

3.1

3.3

—

Acute sinusitis

120

3.56

14.05

2.8

1.7

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

229

2.79

13.97

3.9

2.4

—

Lack of expected normal physiological development

11.64

13.97

4.8

4.6

—

Secondary uncertain malignant neoplasm

15.77

13.90

1.4

3.6

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

12.67

13.86

1.4

2.9

—

Zoster [herpes zoster], including avohilmo

112

3.71

13.85

2.6

1.8

—

Hard cardiovascular diseases

179

2.71

13.83

2.4

3.1

—

Other diseases of liver

10.43

13.69

2.3

1.9

—

Ischemic heart diseases

172

2.74

13.61

2.4

3.1

—

Need for other prophylactic measures

12.89

13.39

5.6

5.5

—

Persons encountering health services in other circumstances, wide

198

2.49

13.26

3.0

2.7

—

Gout, FINNGEN

6.02

13.25

1.3

1.2

—

Congenital malformations, deformations and chromosomal abnormalities

223

2.76

12.94

4.0

2.4

—

Oesophageal varices

19.20

12.91

3.9

3.5

—

Other and unspecified tonsillitis

3.68

12.84

3.4

2.5

—

Coronary revascularization (ANGIO or CABG)

168

2.71

12.83

2.3

3.2

—

Caries of enamel

206

2.57

12.81

4.1

1.6

—

Excessive attrition of teeth

231

2.74

12.69

4.4

2.2

—

Personal history of other diseases and conditions

10.42

12.67

3.7

1.3

—

Other and unspecified dermatitis

165

3.09

12.56

2.6

—

Other and unspecified iron deficiency

3.81

12.53

3.2

3.1

—

Symptoms and signs involving the skin and subcutaneous tissue

221

2.74

12.49

2.7

—

Major coronary heart disease event

175

2.63

12.43

2.3

3.2

—

Percutaneous Coronary Intervention

168

2.68

12.40

2.3

3.2

—

Pulmonary embolism

5.62

12.39

1.3

1.4

—

Pulmonary heart disease

5.62

12.39

1.3

1.4

—

Haemorrhage from respiratory passages

4.13

12.37

3.5

2.6

—

Syncope and collapse

5.30

12.36

2.6

2.0

—

Heart failure,strict

4.02

12.36

2.3

2.0

—

Rare circulating lymphoid malignancy, including Hilmo

11.77

12.33

5.9

5.8

—

Asthma (only as main-diagnosis), excluding more controls

4.05

12.31

2.6

1.9

—

Hypoplasia of dental enamel, prenatal , including avohilmo

10.12

12.22

6.7

4.5

—

Bleeding

204

2.58

12.17

3.5

2.6

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.89

12.04

5.6

4.8

—

Other postsurgical states

21.36

12.00

4.0

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

6.60

11.85

3.2

2.3

—

Emergency coronary revascularization (for ACS)

178

2.58

11.84

2.3

3.1

—

Malignant neoplasm of digestive organs

5.24

11.82

4.2

1.6

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

13.39

11.80

3.7

1.7

—

Enterocolitis due to Clostridium difficile

14.66

11.77

1.4

3.5

—

Malignant neoplasm of digestive organs, including Hilmo

4.90

11.71

4.0

1.6

—

Myeloid leukaemia

30.40

11.66

1.7

6.4

—

Abnormal findings on diagnostic imaging of lung

3.96

11.62

1.5

1.7

—

Diseases of middle ear and mastoid

177

2.77

11.62

3.5

2.5

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

142

3.16

11.52

3.7

2.1

—

Polyneuropathies and other disorders of the peripheral nervous system

5.24

11.52

3.5

2.4

—

Other bacterial intestinal infections

9.22

11.46

1.8

3.0

—

Cutaneous abscess, furuncle and carbuncle

3.84

11.33

3.3

2.7

—

Tramadol

100

3.13

11.33

1.8

1.4

—

Disorders of tooth development and eruption

5.78

11.31

4.3

1.1

—

Asthma (only as main-diagnosis)

3.76

11.30

2.6

1.9

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

10.53

11.24

1.6

3.3

—

Ascites

25.09

11.13

3.0

1.0

—

Dermatitis

195

2.76

11.05

2.7

2.6

—

Glomerular disorders in diseases classified elsewhere

11.15

11.02

3.4

2.7

—

Osteoporosis

5.32

10.90

3.9

3.1

—

Explicit bacterial Sepsis

11.91

10.81

3.6

4.3

—

Explicit bacterial Sepsis, including avohilmo

11.91

10.81

3.6

4.3

—

Intestinal stricture

4.22

10.53

2.7

2.5

—

Budesonide

11.20

10.53

1.8

1.6

—

Osteopathies and chondropathies

171

2.78

10.46

3.3

2.8

—

Asthma

3.55

10.43

2.5

1.9

—

Heart failure, strict

3.52

10.40

2.3

2.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

159

2.58

10.36

2.5

1.9

—

Cystic kidney disease

16.19

10.36

3.6

6.6

—

Acute laryngitis and tracheitis

5.18

10.34

4.8

4.4

—

Presence of cardiac and vascular implants and grafts

4.84

10.33

1.5

1.2

—

Asthma-related pneumonia

132

3.10

10.18

3.1

3.8

—

Autoimmune diseases excluding thyroid diseases

232

2.20

10.16

2.3

3.1

—

Anxiety disorders, excluding more controls

163

2.55

10.12

3.7

1.9

—

Asthma, hospital admissions 3, pneumonia

133

3.08

10.06

3.1

3.9

—

Asthma-related pneumonia or sepsis

133

3.08

10.06

3.1

3.9

—

Herpesviral [herpes simplex] infections

11.28

10.04

3.1

2.7

—

Opioids

125

2.64

10.03

2.4

1.7

—

5-aminosalicylic acid

5.01

10.03

1.6

2.5

—

Cystic kidney disease, including avohilmo

14.70

10.00

3.6

6.1

—

Persons encountering health services for examination and investigation

3.99

9.97

3.5

1.3

—

Autoimmune diseases excluding thyroid diseases, strict definition

228

2.20

9.95

2.3

3.1

—

Stomatitis and related lesions

4.04

9.93

7.0

3.6

—

Neurotic, stress-related and somatoform disorders

218

2.34

9.85

4.0

2.2

—

Asthma, excluding more controls

3.58

9.78

2.6

1.9

—

DVT of lower extremities and pulmonary embolism

3.82

9.57

1.3

1.5

—

Anxiety disorders

220

2.31

9.56

4.0

2.2

—

Certain conditions originating in the perinatal period

103

3.21

9.42

4.7

4.6

—

Cerebrovascular diseases (FINNGEN)

4.68

9.39

2.8

2.2

—

Acute bronchiolitis

101

3.24

9.35

4.5

5.1

—

Other and unspecified disorders of white blood cells

21.83

9.35

2.9

3.0

—

Congenital malformations of the circulatory system

125

3.04

9.33

5.3

4.6

—

Recurrent aphthous stomatitis , including avohilmo

4.35

9.31

7.8

4.1

—

Abnormalities of breathing

193

2.28

9.27

2.8

2.6

—

Paralytic ileus and intestinal obstruction

4.49

9.27

2.9

2.4

—

Candidiasis

8.66

9.27

3.2

2.3

—

Non-ischemic cardiomyopathy

4.43

9.24

2.6

—

Gout

4.49

9.24

1.3

1.4

—

Acute peritonitis

13.70

9.17

3.6

4.5

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

154

2.71

9.17

1.6

2.5

—

Hyperkinetic disorders, excluding more controls

3.74

9.13

4.6

3.3

—

Emotional disorders starting during childhood or adolecense, excluding more controls

4.66

9.10

6.3

4.2

—

All-cause Heart Failure

3.38

9.07

2.4

2.0

—

Asthma, unspecified (mode), excluding more controls

3.84

9.05

2.2

2.0

—

Diseases of the skin and subcutaneous tissue

159

2.34

9.03

3.1

2.5

—

Other disorders of white blood cells

15.65

9.03

3.2

3.3

—

Other infectious diseases

15.62

9.02

1.7

3.0

—

Streptococcal septicaemia

10.04

9.01

3.6

4.6

—

Other complications of surgical and medical care, not elsewhere classified

10.03

9.01

2.5

3.5

—

Hypo-osmolality and hyponatraemia

8.21

8.99

3.6

2.0

—

Other endocrine disorders

3.45

8.97

5.3

5.4

—

Heart failure and coronary heart disease

4.02

8.88

2.2

2.4

—

Other infectious diseases, including avohilmo

12.54

8.85

1.8

2.8

—

Congenital malformations of heart and great arteries

119

3.03

8.80

4.6

5.1

—

Streptococcal septicaemia, including avohilmo

9.48

8.76

3.6

4.6

—

Other disorders starting during childhood or adolescence

107

3.17

8.73

5.7

5.1

—

Other congenital malformations of urinary system

17.21

8.67

4.4

7.9

—

Open bite

3.96

8.60

4.0

5.2

—

Other respiratory disorders and diseases

4.38

8.60

2.6

3.9

—

Other diseases of the respiratory system

4.38

8.60

2.6

3.9

—

Disorders of refraction and accommodation

174

2.64

8.59

5.0

3.6

—

Other and unspecified drugs and medicaments

11.58

8.56

2.9

3.8

—

Statin medication

120

2.58

8.53

3.4

1.9

—

Depression medications

6.37

8.51

3.8

2.3

—

Venous thromboembolism

101

3.15

8.40

1.5

—

Asthma, unspecified (mode)

3.61

8.36

2.2

2.0

—

Procreative management

167

2.52

8.34

3.4

4.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

101

3.17

8.33

2.5

2.9

—

Diseases of the eye and adnexa

182

2.18

8.26

3.3

2.9

—

Autoimmune diseases related-to ILD

238

2.25

8.19

2.5

2.6

—

Pacemaker

4.09

8.10

2.7

2.5

—

Tooth eruption problems

114

2.97

8.09

5.5

4.3

—

Other diseases of hard tissues of teeth

3.27

8.07

4.7

1.1

—

Complications of procedures, not elsewhere classified

161

2.50

8.05

2.7

2.2

—

Iron deficiency anaemia secondary to blood loss (chronic)

6.80

8.04

3.0

2.8

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

8.92

8.03

2.8

4.3

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

22.10

8.01

5.8

3.6

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

22.10

8.01

5.8

3.6

—

Cardiomyopathies, Primary/intrinsic

7.22

7.94

3.0

3.2

—

Noninfective enteritis and colitis

224

2.37

7.93

2.1

3.4

—

Dermatitis and eczema

252

2.02

7.84

2.6

2.9

—

Non-invasive ventilation

3.77

7.77

4.8

2.2

—

Diseases of peritoneum

9.40

7.77

3.6

3.5

—

Cardiomyopathy (excluding other)

6.94

7.75

3.0

3.3

—

Other noninfective gastroenteritis and colitis

133

2.78

7.70

2.4

3.9

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

238

2.29

7.67

4.7

3.1

—

Preparatory care for dialysis

18.44

7.60

3.0

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

18.40

7.60

5.8

3.2

—

Other diseases of intestines

260

1.95

7.44

3.0

3.1

—

Astigmatism

3.90

7.41

4.7

5.3

—

Cellulitis

3.34

7.36

3.4

3.2

—

Asthma (mode)

3.05

7.33

2.7

1.9

—

Hepatomegaly and splenomegaly, not elsewhere classified

+∞

7.31

3.9

0.0

—

Hepatocellular carcinoma

+∞

7.30

4.0

0.0

—

Multiple myeloma

+∞

7.30

1.9

0.0

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

+∞

7.30

1.9

0.0

—

Childhood asthma (age<16)

7.39

7.30

3.8

—

Cardiac arrhythmias

132

2.43

7.20

2.3

3.1

—

Urticaria and erythema

162

2.53

7.13

4.2

3.4

—

Childhood asthma (age<16), excluding more controls

7.82

7.13

4.0

3.8

—

Disorders of lens

110

2.54

7.02

2.4

1.8

—

Diseases of the respiratory system

3.10

6.99

3.5

2.0

—

Atrial fibrillation and flutter

4.30

6.95

1.8

1.4

—

Deep bite

112

2.75

6.95

4.8

4.6

—

Drug-induced polyneuropathy

14.17

6.94

5.3

5.4

—

Special screening examination for infectious and parasitic diseases

4.53

6.94

2.2

1.2

—

Polyarthropathies

159

2.26

6.93

1.6

2.7

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

5.48

6.92

4.7

4.8

—

Other necrotizing vasculopathies

13.80

6.88

4.5

4.4

—

Other cataract

3.12

6.87

3.1

1.9

—

Cardiomyopathy, other and unspecified

10.94

6.79

2.3

3.9

—

Acute generalized exanthematous pustulosis

9.34

6.78

2.2

5.6

—

Gingivitis and periodontal diseases

163

2.12

6.74

4.3

2.3

—

Dentofacial anomalies [including malocclusion]

195

2.21

6.74

3.3

2.0

—

Other diseases of pleura

2.87

6.64

2.5

—

Volume depletion

7.80

6.60

4.2

3.8

—

6-mercaptopurine

12.29

6.58

4.9

3.8

—

Emotional disorders and disorders of social functioning with onset specific to childhood

3.28

6.58

6.1

5.0

—

Herpesviral [herpes simplex] infections, including avohilmo

3.56

6.57

2.9

2.1

—

Disturbance of activity and attention

103

2.85

6.52

4.7

4.0

—

225

2.21

6.43

2.9

3.5

—

Erysipelas, including avohilmo

2.78

6.43

1.6

1.7

—

Hernia

206

2.06

6.43

2.8

2.4

—

Varicella [chickenpox]

7.41

6.41

3.4

4.6

—

Hypokalaemia

7.38

6.40

2.6

3.8

—

Systemic connective tissue disorders

3.29

6.39

3.3

2.2

—

Malnutrition

6.62

6.35

4.6

5.9

—

Exclusions for E4_PCOS_BROAD

113

2.75

6.34

3.4

4.5

—

Melanocytic naevi

3.03

6.32

4.0

2.2

—

Symptoms and signs involving the circulatory and respiratory systems

193

1.97

6.32

3.5

2.6

—

Follow-up examination after treatment for conditions other than malignant neoplasms

3.92

6.30

2.0

1.2

—

Protozoal diseases

18.13

6.27

3.4

3.0

—

Protozoal diseases, including avohilmo

18.12

6.27

3.4

3.0

—

Aspergillosis

+∞

6.27

1.0

0.0

—

Aspergillosis, including avohilmo

+∞

6.27

1.0

0.0

—

Multiple myeloma and malignant plasma cell neoplasms

18.08

6.26

1.7

3.6

—

Primary biliary cholangitis (PBC)

+∞

6.26

1.2

0.0

—

IgA nephropathy (IgA glomerulonephritis)

+∞

6.25

3.3

0.0

—

Paroxysmal tachycardia

4.16

6.20

2.9

4.3

—

Disorders in reading

6.36

6.19

8.2

6.3

—

Nonischemic cardiomyopathy

7.66

6.11

2.6

3.4

—

Non-allergic asthma (mode), excluding more controls

6.20

6.10

3.7

2.8

—

Non-allergic asthma (mode)

6.20

6.10

3.7

2.9

—

Left ventricular outflow tract obstruction, narrow definition

3.77

6.09

5.1

5.5

—

Other necrotizing vasculopathies (FG)

12.54

6.08

4.7

4.4

—

Diseases of arteries, arterioles and capillaries

107

2.54

6.08

2.4

1.7

—

Other disorders of skin and subcutaneous tissue

183

2.21

6.06

2.8

2.3

—

Inflammatory bowel disease

116

2.68

6.06

1.7

3.4

—

Dermatitis due to substances taken internally

8.61

6.05

2.3

6.8

—

Phobic anxiety disorders

3.58

6.00

3.6

3.2

—

Other and unspecified immunodeficiencies with predominantly antibody defects

15.25

5.92

5.6

4.8

—

Viral pneumonia (unknown virus, not influenza)

7.25

5.92

2.7

—

Melanocytic naevi of trunk

5.78

5.82

4.3

2.5

—

Other pulmonary heart/vessel disease

11.16

5.79

2.3

5.4

—

Asthma, hospital admission 2, infections

258

2.04

5.73

2.8

3.2

—

Asthma-related infections

258

2.04

5.73

2.8

3.2

—

Acute lymphocytic leukaemia

7.80

5.69

7.7

5.8

—

Acute lymphocytic leukaemia, helper endpoint

7.80

5.69

7.7

5.8

—

Acute lymphocytic leukaemia, including Hilmo

7.80

5.69

7.7

5.8

—

Used for control exclusion in common control thyroid runs

228

1.84

5.65

2.7

3.1

—

Hypothyroidism, levothyroxine purchases

5.98

5.64

2.8

2.5

—

Hypothyroidism and >3 levothyroxin purchases

5.98

5.64

2.8

2.5

—

Hypothyroidism (congenital or acquired)

5.97

5.63

2.8

2.5

—

Varicella [chickenpox], including avohilmo

4.75

5.60

3.1

4.5

—

Osteonecrosis

12.90

5.58

3.2

1.0

—

Pain (limb, back, neck, head abdominally)

140

2.08

5.56

3.9

3.0

—

Elevated blood glucose level

6.52

5.55

4.7

5.3

—

Undetermined asthma

8.46

5.55

2.6

3.7

—

Undetermined asthma, excluding more controls

8.46

5.55

2.6

3.7

—

Other or unspecified ileus, impaction or obstruction

5.36

5.52

2.9

2.3

—

Continuous positive airway pressure

3.05

5.44

3.9

3.3

—

Hydronephrosis

7.07

5.43

3.8

4.0

—

Anaemia in chronic diseases classified elsewhere

16.12

5.41

4.8

—

Short stature, not elsewhere classified

2.88

5.41

5.9

5.5

—

Autoimmune diseases

237

1.80

5.40

2.5

3.1

—

Acute pancreatitis

5.18

5.38

3.9

1.8

—

Generalized skin eruption due to drugs and medicaments

7.90

5.34

2.5

5.6

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

3.55

5.32

3.3

5.0

—

Alcoholic liver disease

11.27

5.29

1.0

—

Candidiasis, including avohilmo

2.91

5.28

3.1

2.0

—

Viral hepatitis, including avohilmo

6.69

5.25

3.9

2.1

—

Hypertension, Pulmonary Arterial

+∞

5.22

1.8

0.0

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

+∞

5.22

2.2

0.0

—

Disorders of brain, other and unspecified

+∞

5.22

3.8

0.0

—

Chronic hepatitis NAS

+∞

5.22

1.2

0.0

—

Myelodysplastic syndrome

+∞

5.21

1.4

0.0

—

Cough

151

2.29

5.20

3.9

3.0

—

Ulcerative colitis, NAS

3.64

5.19

1.8

4.3

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

3.34

5.15

1.3

3.4

—

Covid-19 suspected case

3.00

5.09

3.0

3.3

—

Vitamin deficiency, wide

13.38

5.08

4.3

2.8

—

Vitamin deficiency

13.38

5.08

4.3

2.8

—

Tubulo-interstitial nephritis, not specified as acute or chronic

13.36

5.08

2.0

4.3

—

Personal history of malignant neoplasm

13.36

5.07

4.3

1.3

—

Inflammatory bowel disease, strict (require KELA)

2.84

5.07

1.4

3.9

—

IBD patients in KELA-register

2.84

5.07

1.4

3.8

—

Immunodeficiency with predominantly antibody defects

8.40

5.06

6.0

5.7

—

Other diseases of arteries and capillaries

8.35

5.05

1.4

3.7

—

Adjustment and management of implanted device

5.66

5.05

2.2

3.8

—

Finngen Rheumatological endpoints

195

1.89

5.04

2.2

2.8

—

Benign neoplasms

206

1.85

5.02

2.7

—

Viral pneumonia (known virus, not influenza)

6.93

4.96

3.5

5.4

—

Viral hepatitis

6.89

4.95

4.2

2.1

—

Disorders of mineral metabolism

6.89

4.95

3.6

—

Delayed milestone in childhood

2.64

4.94

5.5

5.6

—

Bacterial, viral and other infectious agents

5.01

4.93

4.8

3.7

—

Codeine

116

2.14

4.91

1.8

1.4

—

Unspecified acute lower respiratory infection

3.48

4.88

2.2

3.3

—

Acute pancreatitis (for exclusion)

4.55

4.85

3.9

2.1

—

Any mental disorder

191

1.84

4.82

3.5

2.2

—

Other and unspecified polyneuropathies, also in other diseases

4.83

4.80

2.1

1.2

—

Erysipelas

2.87

4.79

1.9

1.7

—

Other encephalitis

11.50

4.79

1.4

7.1

—

Other diseases of pericardium

9.04

4.78

1.7

4.6

—

Other viral hepatitis, including avohilmo

6.49

4.77

4.2

2.2

—

Invasive ventilation

5.22

4.76

2.9

3.9

—

Ulcerative colitis

2.74

4.76

1.9

3.4

—

Cholecystitis

7.15

4.64

2.1

1.8

—

Other skin changes

4.29

4.62

1.8

2.8

—

Congenital vesicoureteral reflux

8.44

4.60

4.4

7.7

—

Pain in throat and chest

169

1.93

4.58

2.6

2.4

—

Intestinal malabsorption

14.04

4.57

2.7

4.0

—

Other aneurysm

14.04

4.57

5.3

1.4

—

Sequelae of other external causes

14.03

4.57

3.3

2.8

—

Viral hepatitis, IBD co-morbidity

14.03

4.57

1.3

1.2

—

Motor disorders, excluding more controls

3.39

4.56

5.8

4.6

—

Anti-inflammatory and antirheumatic products, non-steroids

119

0.21

4.54

4.0

4.4

—

Ischaemic heart disease, wide definition

106

2.21

4.52

1.7

1.1

—

Polycystic kidney disease

10.07

4.52

3.6

5.1

—

Encephalitis

10.06

4.52

1.4

6.5

—

Adrenocortical insufficiency

10.05

4.52

4.4

5.1

—

Diaphragmatic hernia

3.05

4.50

2.3

1.3

—

Specific development disorders of speech and language

2.61

4.49

4.6

5.0

—

Abnormal serum enzyme levels

2.96

4.48

3.0

2.6

—

Cholelithiasis, broad definition with cholecystitis

125

2.13

4.46

2.4

1.5

—

Fitting and adjustment of other devices

3.48

4.44

2.6

2.4

—

Bacterial, viral and other infectious agents, including avohilmo

4.39

4.43

4.8

3.6

—

Emotional disorders starting during childhood or adolescence

2.71

4.42

6.2

5.3

—

Sequelae of external causes of morbidity and mortality

3.09

4.35

3.0

2.7

—

Immunodeficiencies

5.02

4.31

5.2

4.9

—

Other viral hepatitis

6.27

4.29

4.5

2.1

—

102

2.47

4.29

4.1

5.4

—

Factors influencing health status and contact with health services

5.44

4.29

2.3

1.1

—

Inflammatory diseases of the central nervous system

5.51

4.28

1.7

4.0

—

Benign neoplasm: Skin of trunk

11.71

4.27

2.6

3.7

—

ILD, hospital admissions 3, with pneumonia sepsis

11.68

4.27

1.3

2.7

—

ILD, hospital admission 2, with pulmonary infections

11.68

4.27

1.3

1.0

—

Other symptoms and signs involving the digestive system and abdomen

4.49

4.24

3.3

3.1

—

Presence of other devices

5.41

4.22

3.8

1.1

—

Noninfectious colitis NAS

3.14

4.20

2.8

4.4

—

Tooth agenesis EXCLUDE clefts and syndromes

3.15

4.20

3.9

5.7

—

Crohn disease

3.27

4.18

1.5

4.3

—

Diseases of salivary glands

2.66

4.14

1.6

2.6

—

Dilated cardiomyopathy

5.25

4.14

2.4

2.9

—

Pruritus

5.89

4.12

4.4

3.2

—

Congenital malformations of aortic and mitral valves

4.02

4.10

5.4

5.9

—

Urticaria

141

2.20

4.09

4.6

3.5

—

Haemorrhagic and haematological disorders of fetus and newborn

2.46

4.09

6.4

5.3

—

Valvular heart disease excluding rheumatic fever

107

2.20

4.09

3.7

3.2

—

Other diseases of intestine

4.62

4.05

3.8

2.3

—

Other disorders of bone

3.19

4.05

4.1

3.2

—

Diseases of oesophagus, stomach and duodenum

233

1.72

4.04

2.1

2.7

—

Propionic acid derivatives

119

0.25

4.02

5.3

4.4

—

Post-traumatic stress disorder

5.56

3.97

2.4

4.4

—

Other arthritis (FG)

2.48

3.95

1.6

2.7

—

Dyspnoea

226

1.79

3.94

2.2

2.6

—

Diverticular disease of intestine

2.24

3.89

1.4

1.3

—

Mucosal proctocolitis

3.79

3.88

1.2

3.6

—

Type of accident

100

2.40

3.88

4.0

2.8

—

Gout, unspecified

4.79

3.86

1.6

1.1

—

Malignant neoplasm of eye, brain and central nervous system

7.30

3.86

1.5

4.1

—

Disorders of skin appendages

191

1.98

3.85

2.8

2.9

—

Distal bite

2.63

3.84

4.7

4.9

—

Neurological diseases, wide definition

2.29

3.84

4.5

4.4

—

Collagenous colitis

5.27

3.82

1.8

3.6

—

Haemolytic anaemias

6.03

3.82

7.6

4.3

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

6.01

3.81

1.7

4.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

3.07

3.80

1.3

3.5

—

Ulcerative colitis (strict definition, require KELA)

3.07

3.80

1.3

3.5

—

Phlebitis and thrombophlebitis (not including DVT)

3.94

3.78

1.6

1.8

—

Chronic periodontitis, including avohilmo

164

1.87

3.78

1.7

1.6

—

Valvular operations

3.19

3.77

3.3

3.8

—

Drug-induced adrenocortical insufficiency

12.09

3.77

4.3

4.8

—

Granulomatous disorders of skin and subcutaneous tissue

12.06

3.76

1.7

6.8

—

Periodontitis

164

1.86

3.76

1.7

1.6

—

Other specified disorders of kidney and ureter

12.05

3.76

2.0

3.6

—

Persons encountering health services in circumstances related to reproduction

223

1.74

3.72

3.2

3.3

—

Coronary atherosclerosis

2.33

3.71

1.2

1.1

—

Mood disorders, excluding more controls

160

1.84

3.68

2.4

1.8

—

Infections with a predominantly sexual mode of transmission

2.50

3.68

3.0

1.9

—

Leisure time condition

3.00

3.68

4.7

3.4

—

Hypermetropia

2.79

3.68

5.1

5.0

—

Malignant neoplasm of brain, including Hilmo

6.69

3.67

1.8

4.5

—

Cholelithiasis

121

2.03

3.64

2.3

1.5

—

Other disorders of urethra and urinary system

143

1.95

3.63

2.6

—

Other disorders of lacrimal gland

2.47

3.62

4.6

2.2

—

Other respiratory diseases principally affecting the interstitium

4.40

3.61

1.3

1.6

—

AV-block

4.10

3.58

2.7

3.6

—

Other disorders of adrenal gland

4.78

3.55

3.9

5.0

—

Dermatophytosis

4.77

3.55

2.4

3.6

—

Diseases of the ear and mastoid process

204

1.67

3.53

2.7

2.2

—

Cerebral cysts

6.17

3.50

3.4

4.9

—

Persons encountering health services for specific procedures, not carried out

6.16

3.50

1.1

3.5

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

2.50

3.50

4.4

5.2

—

Degenerative macular diseases

10.01

3.49

3.2

1.2

—

Embedded and impacted teeth

121

2.08

3.48

3.5

3.6

—

2.93

3.47

2.1

1.2

—

Aortic aneurysm

4.15

3.43

2.3

1.1

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

113

2.21

3.40

3.8

2.9

—

Other embolism and thrombosis

5.01

3.36

1.7

2.4

—

Other diseases of pancreas

7.01

3.36

1.1

1.7

—

Other diseases of anus and rectum

2.65

3.36

2.6

—

2.31

3.36

4.2

5.4

—

Hyperkinetic disorders

143

2.05

3.35

4.7

4.4

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

4.39

3.31

4.2

6.3

—

Fracture of skull and facial bones

2.54

3.28

2.2

3.0

—

Rash and other nonspecific skin eruption

3.94

3.28

4.9

4.4

—

Symptoms and signs involving the urinary system

195

1.78

3.27

2.7

2.4

—

Other and unspecified erythematous conditions

8.60

3.26

3.7

6.0

—

Viral conjunctivitis, including avohilmo

8.60

3.26

2.7

5.7

—

Attention to artificial openings

8.60

3.26

5.3

4.7

—

Other diseases of blood and blood-forming organs

8.59

3.26

1.3

2.0

—

Migraine

174

1.83

3.23

3.5

3.1

—

Unspecified haematuria

2.33

3.23

3.9

2.1

—

Hypertension, essential

108

1.94

3.19

1.6

—

COPD-related respiratory insufficiency

5.34

3.19

1.5

1.1

—

Other congenital malformations of heart

4.62

3.14

3.7

5.8

—

Congenital malformations of cardiac septa

101

2.21

3.12

4.5

5.1

—

Congenital deformities of feet, including avohilmo

4.52

3.11

2.1

5.4

—

Polyuria

3.43

3.10

1.2

1.8

—

Nail disorders

4.01

3.08

2.5

3.4

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

4.00

3.08

1.5

2.7

—

Early onset COPD, excluding more controls

4.00

3.07

1.4

1.1

—

Other and unspecified urticaria

2.33

3.07

3.1

4.2

—

Idiopathic thrombocytopenic purpura

7.53

3.05

4.8

6.1

—

Other erythematous conditions

7.53

3.05

3.7

5.4

—

Malignant neoplasm of brain

7.53

3.05

1.7

4.4

—

Retinal vascular occlusion

7.51

3.05

1.5

1.1

—

Retinal vascular disorders

7.51

3.05

1.5

1.1

—

Migraine without aura and triptan purchases

2.68

3.05

5.6

2.6

—

Erectile dysfunction

5.01

3.05

5.4

2.1

—

Seborrhoeic dermatitis

5.01

3.05

2.7

4.6

—

Migraine with aura

2.38

3.05

2.7

2.8

—

Malignant neoplasm of skin

2.61

3.02

1.1

1.3

—

Non-rheumatic valve diseases

2.06

3.02

3.4

2.8

—

COPD (mode)

3.73

3.02

1.0

1.2

—

Other coagulation defects

5.84

3.02

2.9

4.0

—

Benign neoplasm: Transverse colon

5.84

3.02

1.3

1.2

—

Sequelae with surgical and medical care as external cause

3.34

3.01

2.9

2.4

—

Psychiatric diseases

183

1.64

2.99

3.9

2.3

—

Acidosis

10.05

2.98

2.2

3.0

—

Myopia

2.75

2.98

5.5

3.9

—

Small fibre neuropathy

10.04

2.98

3.0

—

Scleritis and episcleritis

10.02

2.98

1.0

1.4

—

Lichen simplex chronicus and prurigo

10.01

2.98

1.0

3.2

—

Examination and encounter for administrative purposes

10.01

2.98

2.4

1.0

—

Other arrhythmias

139

1.88

2.97

1.6

2.5

—

Speech therapy

2.63

2.96

2.5

2.6

—

Skin changes due to chronic exposure to nonionizing radiation

2.87

2.92

2.2

1.1

—

Irregular menses

2.05

2.91

2.5

2.2

—

Aortic valve malfunction, age under 60 years

3.44

2.89

2.8

4.1

—

Seborrhoeic keratosis

3.44

2.89

2.5

1.2

—

COPD, hospital admission 2, with asthma infections

2.87

2.89

1.3

1.4

—

Emphysema

6.68

2.86

1.7

2.3

—

Other ill-defined and unspecified causes of mortality

6.67

2.86

1.3

1.6

—

Benign neoplasm of major salivary glands

6.67

2.86

1.5

1.2

—

Ill-defined and unknown causes of mortality

6.67

2.86

1.3

1.6

—

Specific developmental disorder of motor function

2.51

2.81

5.8

5.6

—

Congenital absence, atresia and stenosis of large intestine

9.01

2.80

3.6

6.2

—

Gout, idiopatic and unspecified

3.34

2.80

1.6

1.1

—

Crohn's disease of small intestine

4.45

2.79

1.9

4.3

—

Ulcer of lower limb, not elsewhere classified

4.45

2.79

1.3

2.6

—

Atrophic disorders of skin

3.92

2.77

5.4

2.6

—

Missing teeth due to accident, extraction or parodontitis

128

1.95

2.76

1.2

1.7

—

Otitis externa, unspecified

3.08

2.76

5.8

4.4

—

Excessive, frequent and irregular menstruation

2.26

2.76

4.3

2.2

—

Acquired haemolytic anaemia

8.37

2.75

3.2

5.3

—

Pneumonia due to Streptococcus pneumoniae

8.35

2.75

3.4

3.8

—

Monoarthritis, not elsewhere classified

8.35

2.75

1.0

3.2

—

Pneumothorax

8.34

2.75

1.2

1.5

—

Benign neoplasm: Parotid gland

8.34

2.75

1.6

1.0

—

Other specified/unspecified arthritis

2.20

2.72

1.6

3.0

—

Methotrexate

5.00

2.72

1.0

1.6

—

Impetigo

3.25

2.72

4.1

5.4

—

Depression

229

1.61

2.70

2.5

2.3

—

Other and unspecified coagulation defects

6.01

2.70

1.7

4.1

—

Chronic sinusitis

125

2.00

2.68

4.9

1.7

—

Diseases of pulp and periapical tissues and dental caries

1.91

2.64

3.7

2.1

—

Atopic dermatitis, strict definition with reimbursement

162

1.84

2.61

3.3

3.9

—

Neonatal jaundice from other and unspecified causes

2.23

2.60

7.6

5.4

—

Other condition

3.34

2.60

3.3

3.1

—

Chronic pancreatitis

4.67

2.59

2.7

1.2

—

Benign neoplasm: Ascending colon

4.67

2.59

1.3

1.2

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

3.14

2.58

1.4

1.3

—

Other diseases of urinary system

224

1.55

2.58

2.7

2.9

—

Malignant neoplasm of skin, including Hilmo

2.27

2.58

1.1

1.2

—

Conjunctivitis (acute, non atopic)

162

1.85

2.57

2.9

4.0

—

DVT of lower extremities

4.00

2.56

1.0

1.2

—

Postprocedural disorders of digestive system, not elsewhere classified

7.16

2.55

2.2

4.3

—

Hypermobility syndrome

7.15

2.55

3.2

5.6

—

Family history of malignant neoplasm

7.15

2.55

2.2

1.3

—

Chronic gastritis

2.86

2.54

1.4

1.5

—

Atrial septal defect

2.35

2.52

4.3

5.1

—

Infectious mononucleosis

3.23

2.51

2.9

3.4

—

Infectious mononucleosis, including avohilmo

3.23

2.51

2.9

3.4

—

Other and unspecified local infections of skin and subcutaneous tissue

3.23

2.51

6.3

4.0

—

Other local infections of skin and subcutaneous tissue

3.23

2.51

6.3

4.0

—

Dementia

0.00

2.50

0.0

1.5

—

Mycoses, including avohilmo

268

1.56

2.49

2.3

2.6

—

Pain in joint

116

1.80

2.48

2.0

2.7

—

Dysphagia

2.97

2.48

3.1

1.5

—

Exposure to unspecified factor

304

1.50

2.48

3.0

2.8

—

Impacted teeth

104

1.98

2.47

3.7

3.8

—

ILD, hospital admissions 1, main diag only

3.81

2.46

1.3

1.7

—

Major coronary heart disease event excluding revascularizations

2.07

2.42

1.6

1.4

—

Persons encountering health services in other circumstances

129

1.92

2.42

3.5

2.7

—

Tonsillectomy and adenotomy

230

1.57

2.41

4.6

3.2

—

Ingrowing nail

5.01

2.40

3.2

3.9

—

Abnormal findings on diagnostic imaging of other body structures

3.34

2.39

1.1

2.9

—

Complex cardiac defects

4.21

2.38

4.6

5.9

—

Disorders of speech understanding and production

2.28

2.38

4.7

5.3

—

Oesophagitis

6.26

2.37

2.8

—

Other and unspecified disorders of skin and subcutaneous tissue

6.26

2.37

2.0

3.6

—

Corns and callosities

6.26

2.37

2.0

2.4

—

Benign neoplasm: salivary glands, exclude unknown (D119)

6.26

2.37

1.6

1.3

—

Congenital deformities of feet

4.14

2.36

2.4

6.0

—

Misadventures to patients during surgical and medical care

3.64

2.36

2.8

2.6

—

Presence of other functional implants

2.28

2.36

2.3

1.2

—

Disorders of parathyroid gland

3.30

2.36

2.6

1.6

—

Asthma, hospital admissions , main diagnosis only

306

1.53

2.34

2.8

2.9

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.82

2.34

3.4

1.9

—

Hypothyroidism, drug reimbursement

5.24

2.33

3.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2.41

2.32

1.0

1.3

—

Insulin, combination of fast acting with intermediate-acting or long-acting

193

1.69

2.31

3.0

2.9

—

Diseases of oral cavity, salivary glands and jaws

2.04

2.31

4.4

1.1

—

Weight loss

3.22

2.30

5.8

5.0

—

Dental caries, including avohilmo

1.78

2.30

3.5

2.0

—

Follicular cysts of skin and subcutaneous tissue

2.94

2.27

1.3

1.9

—

Congenital malformations of great veins

4.04

2.27

3.9

5.2

—

Other and unspecified injuries of ankle and foot

4.63

2.27

2.3

3.7

—

Hyperfunction of pituitary gland

4.63

2.27

2.5

4.2

—

Vulvovaginal ulceration/inflammation in other diseases

4.62

2.27

6.2

2.2

—

Viral infections of the central nervous system, including avohilmo

4.62

2.27

3.8

2.7

—

Intestinal adhesions without obstruction

4.62

2.27

2.8

2.0

—

ILD, hospital admissions

3.48

2.26

1.3

1.6

—

Cardiac arrest

6.07

2.26

1.8

3.3

—

Mood [affective] disorders

230

1.53

2.25

2.5

2.3

—

Acute lymphadenitis

3.90

2.25

5.4

5.1

—

Mood disorders

230

1.53

2.24

2.5

2.3

—

Diseases of the musculoskeletal system and connective tissue

155

1.59

2.22

3.9

3.8

—

Juvenile osteochondrosis

5.57

2.21

2.8

5.6

—

Disorders of puberty, all

2.88

2.21

3.7

6.9

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

5.56

2.21

2.6

3.4

—

Seropositive rheumatoid arthritis

3.09

2.21

1.4

1.1

—

Hernia of abdominal wall

128

1.88

2.20

2.0

2.2

—

Contact with and exposure to communicable diseases

171

1.75

2.20

4.5

3.3

—

Angina pectoris

2.10

2.18

1.7

1.1

—

Interstitial lung disease

3.34

2.18

1.3

1.6

—

Other interstitial pulmonary diseases

3.34

2.18

1.3

1.6

—

Interstitial lung disease endpoints

3.34

2.18

1.3

1.6

—

Senile cataract

1.90

2.17

1.2

1.1

—

4.31

2.15

6.8

4.6

—

Pneumonia derived septicemia

4.30

2.15

4.3

5.3

—

Hordeolum and other deep inflammation of eyelid

3.69

2.15

4.0

4.4

—

Other Crohn's disease

3.69

2.15

1.1

4.6

—

Impacted maxillary molar

3.01

2.14

2.7

4.0

—

Chondropathies

2.62

2.14

4.1

2.9

—

Basal cell carcinoma, including Hilmo

2.37

2.11

1.0

1.2

—

Benign neoplasm of other and ill-defined parts of digestive system

3.20

2.09

1.1

1.6

—

Umbilical hernia

2.13

2.08

1.9

2.1

—

Other ulcerative colitis

5.01

2.07

1.4

3.4

—

Pneumonitis due to solids and liquids

5.00

2.07

1.2

3.3

—

Other diseases of oesophagus

5.00

2.07

2.8

1.1

—

All anxiety disorders

182

1.62

2.06

4.0

2.3

—

Eustachian salpingitis and obstruction

3.50

2.05

4.7

3.4

—

Thoracic aortic aneurysm

3.50

2.05

3.0

1.2

—

Hyperparathyroidism

3.46

2.03

1.1

1.3

—

Motor disorders

2.12

2.00

5.8

6.0

—

Cerebral palsy and other paralytic syndromes

2.63

2.00

3.3

4.6

—

Other gastritis (incl. Duodenitis)

2.63

2.00

1.2

2.1

—

Lung diseases due to external agents

3.34

1.96

2.0

2.4

—

Otitis externa

2.03

1.95

5.1

3.3

—

Contraceptive management

102

1.78

1.94

2.6

1.5

—

Infections with a predominantly sexual mode of transmission, including avohilmo

122

1.80

1.94

2.7

2.0

—

Chronic viral hepatitis

4.55

1.94

1.2

1.0

—

Disorders of calcium metabolism

4.55

1.94

2.6

4.0

—

Bronchiectasis

4.55

1.94

2.8

4.3

—

Viral infections of the central nervous system

4.55

1.94

4.2

2.2

—

Peripheral artery operations in Hilmo

4.55

1.94

1.0

—

Special screening examination for other diseases and disorders

4.54

1.94

5.2

1.3

—

Intermittent heterotropia

2.19

1.93

5.1

5.0

—

Intracerebral haemorrhage

3.75

1.93

3.3

2.1

—

Dorsalgia

205

1.47

1.93

1.8

2.4

—

Colorectal cancer, including Hilmo

3.26

1.90

2.3

1.3

—

Atrial fibrillation and flutter with reimbursement

2.84

1.89

1.2

1.4

—

Diabetes, varying definitions

231

1.46

1.89

2.5

2.7

—

Diplopia

3.18

1.88

1.9

3.2

—

Disorders of lacrimal system

119

1.82

1.87

4.5

2.4

—

Respiratory and cardiovascular disorders specific to the perinatal period

108

1.84

1.87

4.9

5.5

—

Other disorders of glucose regulation and pancreatic internal secretion

2.65

1.86

3.2

5.0

—

Actinic keratosis

2.57

1.85

2.5

1.2

—

Coeliac disease

2.39

1.85

1.4

5.0

—

Other hearing loss

2.54

1.84

1.1

2.3

—

Other specified/unspecified hearing loss

3.53

1.83

1.0

3.9

—

Peripheral arterial reconstruction

3.53

1.83

1.5

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

190

1.51

1.82

2.4

3.5

—

Foreign body in ear

4.19

1.82

3.4

5.0

—

Viral agents as the cause of diseases classified to other chapters

4.18

1.82

5.0

4.8

—

Iron deficiency

4.18

1.82

2.0

5.0

—

Additional codes for the location of defect, injury or illness

4.17

1.82

1.6

3.9

—

Diabetes mellitus

232

1.44

1.82

2.7

—

Benign neoplasm: Colon

1.90

1.82

1.2

1.3

—

Other anxiety disorders

135

1.70

1.81

4.3

2.3

—

Hydrocele

2.57

1.80

3.2

—

Other/unspecified synovitis and tenosynovitis

3.05

1.80

1.7

1.8

—

Gout, strict definition

3.05

1.79

1.0

—

Other (seronegative) rheumatoid arthritis, wide

3.05

1.79

1.1

1.5

—

Other disorders of optic [2nd] nerve and visual pathways

2.76

1.79

2.5

4.5

—

Other soft tissue disorders, not elsewhere classified

258

1.41

1.78

3.1

3.0

—

KRA_PSY_EATING, excluding more controls

3.02

1.78

2.9

2.7

—

Anxiety (asthma-related co-morbidities)

186

1.55

1.77

4.0

2.5

—

Injuries to the ankle and foot

286

1.46

1.77

3.4

2.7

—

Unspecific neurodegenerative disorder

0.00

1.75

0.0

1.1

—

Migraine without aura

1.90

1.74

5.3

3.8

—

Pediculosis, acariasis and other infestations

3.34

1.74

5.5

2.9

—

Female infertility, cervical, vaginal, other or unspecified origin

2.33

1.74

1.7

1.3

—

Disorders of optic nerve and visual pathways

2.50

1.74

2.3

4.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2.50

1.73

1.4

1.1

—

Other/unspecified seropositive rheumatoid arthritis

2.50

1.73

1.4

1.1

—

Seropositive rheumatoid arthritis, wide

2.50

1.73

1.4

1.1

—

Allergic asthma (mode), excluding more controls

2.69

1.73

3.5

2.6

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

3.50

1.73

1.0

1.8

—

Mandibular retrognathia

2.22

1.72

6.8

5.2

—

Exposure to other and unspecified inanimate mechanical forces

2.67

1.72

2.5

4.1

—

Crohn's disease NAS

2.92

1.72

2.0

5.8

—

Protein-energy malnutrition of moderate and mild degree

3.88

1.72

4.4

5.2

—

Viral agents as the cause of diseases classified to other chapters, including avohilmo

3.86

1.71

5.0

4.5

—

Crohn's disease of large intestine

3.85

1.71

1.2

5.2

—

Scabies

3.85

1.71

6.4

3.6

—

Seronegative rheumatoid arthritis

3.85

1.71

1.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.21

1.71

1.0

1.3

—

Diseases of external ear

140

1.72

1.71

4.6

3.5

—

Polycystic ovarian syndrome, consortium definition

104

1.65

1.71

2.3

2.1

—

Neurological diseases

225

1.41

1.69

3.3

—

Basal cell carcinoma

2.27

1.69

1.0

1.2

—

Rheumatoid arthritis

2.13

1.68

1.4

—

Menorrhagia

2.09

1.67

2.5

2.1

—

Noninflammatory disorders of female genital tract

1.85

1.66

5.0

2.7

—

Crohn disease (strict definition, require KELA, min 2 HDR)

3.16

1.66

1.7

4.7

—

Crohn disease (strict definition, require KELA)

3.16

1.66

1.7

4.7

—

L04AC Interleukin inhibitors

3.16

1.66

1.2

3.2

—

Bell's palsy

3.16

1.66

5.0

1.8

—

Psoriatic and enteropathic arthropathies

3.16

1.66

1.3

1.9

—

Rosacea

3.16

1.66

3.5

2.7

—

Hypoglycaemia, other or unspecified

2.58

1.66

3.5

5.1

—

Radiculopathy

2.80

1.65

1.7

1.4

—

Maternal care for known or suspected fetal abnormality and damage

2.61

1.64

1.1

1.6

—

Cardiac murmurs and other cardiac sounds

1.98

1.64

5.1

4.4

—

Other antidepressants

175

1.46

1.64

1.5

2.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

2.18

1.62

4.8

2.1

—

Pneumococcal septicemia

3.58

1.61

3.8

6.6

—

Contusion of ankle

3.58

1.61

2.6

4.6

—

Dental operations

1.80

1.61

3.5

1.3

—

Early onset COPD

2.38

1.61

1.4

—

Myocardial infarction

1.96

1.61

1.6

1.3

—

Malignant neoplasm of colon, including Hilmo

3.56

1.61

2.8

1.2

—

Insulin medication

196

1.52

1.59

3.0

2.9

—

Other benign neoplasms of skin

1.91

1.59

1.9

2.0

—

Colorectal cancer

3.03

1.58

2.5

1.2

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

2.33

1.58

1.3

3.7

—

Disorders of puberty

2.71

1.58

4.1

6.7

—

Problems related to lifestyle

3.00

1.58

2.2

2.0

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

3.00

1.58

1.5

2.4

—

STROKE

1.70

1.57

2.1

—

Any dementia, excluding more controls

0.00

1.57

0.0

1.3

—

Other disorders of veins

1.94

1.57

1.4

—

Any dementia

0.00

1.57

0.0

1.4

—

Diabetic nephropathy

2.47

1.57

2.9

1.3

—

Fissure and fistula of anal and rectal regions

2.20

1.56

3.1

1.9

—

Other systemic involvement of connective tissue (FG)

2.28

1.55

2.1

2.3

—

Allergic asthma (mode)

2.44

1.54

3.5

2.6

—

Codeine or tramadol medication

176

1.45

1.54

1.7

1.4

—

Retinal detachments and breaks

2.03

1.53

1.8

1.5

—

Biological medication for rheuma

1.97

1.53

1.4

4.2

—

Chronic diseases of tonsils and adenoids

248

1.40

1.53

3.5

2.6

—

Osteomyelitis

3.34

1.52

1.8

4.6

—

Other sexually transmitted chlamydial diseases

3.34

1.52

3.2

2.6

—

Paracetamol or NSAID medication

0.44

1.52

9.9

4.5

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

2.59

1.51

1.0

2.4

—

Female infertility

2.18

1.51

1.9

1.3

—

Coarctation of the aorta

2.88

1.51

5.0

6.5

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

2.86

1.50

1.7

4.4

—

Pleural effusion

2.86

1.50

2.7

1.4

—

Other strabismus

130

1.69

1.50

5.5

4.2

—

Pain in limb

246

1.39

1.49

3.4

3.0

—

Colonic or urogenital fistula

2.07

1.49

3.7

1.8

—

Inguinal hernia

132

1.56

1.48

3.5

2.5

—

Strabismus

154

1.62

1.48

5.3

3.9

—

Vocal cord dysfunction

2.57

1.47

2.7

2.6

—

Gastroduodenal ulcer

2.43

1.47

2.9

1.5

—

Pain associated with micturition

2.50

1.45

1.9

3.5

—

Substance abuse, excluding more controls

129

1.62

1.44

2.2

1.5

—

Plantar fascial fibromatosis

3.13

1.44

2.2

1.5

—

Retinal breaks without detachment

2.73

1.43

2.3

1.4

—

Anterior Iridocyclitis

2.31

1.42

1.2

2.8

—

Primary coxarthrosis, bilateral

2.31

1.42

1.2

1.1

—

Peripheral artery disease

2.06

1.42

1.1

1.4

—

Arthropathies

222

1.37

1.41

2.2

3.5

—

Amblyopia ex anopsia

2.18

1.40

4.9

6.0

—

Outcome of delivery

0.00

1.39

0.0

2.1

—

Hypopituitarism

2.08

1.38

4.3

4.6

—

Conductive hearing loss, unspecified

2.61

1.36

7.7

4.7

—

Perforation of tympanic membrane

2.61

1.36

3.3

3.2

—

Simple and mucopurulent chronic bronchitis

2.95

1.36

2.0

5.2

—

Fall involving playground equipment

0.00

1.35

0.0

5.9

—

Chronic periodontitis, complicated

139

1.61

1.35

1.9

1.3

—

Myocardial infarction, strict

1.91

1.33

1.7

1.3

—

Disorders of thyroid, IBD co-morbidities

2.49

1.33

1.4

3.5

—

Type 2 diabetes, wide definition

129

1.51

1.32

1.5

1.3

—

Diabetic nephropathy, excluding more controls

2.41

1.30

2.9

1.4

—

Thyroiditis, ILD-related definition

2.50

1.30

1.3

4.3

—

Colectomy operation

2.50

1.30

3.2

1.9

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

128

1.63

1.30

3.8

4.5

—

Ventral hernia

2.09

1.30

2.0

1.9

—

Adalimumab

2.36

1.29

1.1

3.3

—

Benign neoplasm of colon, rectum, anus and anal canal

115

1.62

1.29

1.2

1.3

—

Malignant neoplasm of endocrine gland, including Hilmo

2.78

1.28

2.0

3.9

—

Arthropathic psoriasis

2.78

1.28

3.0

1.7

—

Disturbances of skin sensation

1.94

1.27

2.7

2.1

—

Acute and subacute iridocyclitis

2.29

1.26

1.1

2.7

—

COPD, hospital admissions 1, only main diagnosis

2.10

1.26

1.0

1.3

—

Other diseases of lip and oral mucosa

138

1.59

1.25

3.2

2.6

—

Rheumatoid arthritis, including avohilmo

1.82

1.25

1.4

1.7

—

Urinary track infection

107

1.50

1.25

3.3

3.0

—

Biguanides

170

0.60

1.24

1.4

—

Abnormal weight loss

2.40

1.24

2.3

4.7

—

Eating disorders

2.00

1.23

2.8

3.9

—

Congenital malformations and deformations of the musculoskeletal system

115

1.65

1.22

4.1

4.6

—

Other systemic involvement of connective tissue

2.04

1.21

2.1

2.2

—

Other symptoms and signs involving the urinary system

2.63

1.21

1.4

2.3

—

Septal defects

106

1.67

1.21

4.4

5.3

—

Disorders of eyelid, lacrimal system and orbit

228

1.38

1.20

3.8

2.4

—

Myocardial infarction, unclassifiable

2.63

1.20

2.6

1.1

—

Cystitis

179

1.39

1.20

2.5

3.0

—

Congenital malformations of cardiac chambers and connections

2.34

1.19

5.0

6.5

—

Dizziness and giddiness

184

1.44

1.19

2.3

2.1

—

Haemangioma, any site

2.31

1.18

3.5

3.8

—

Salpingitis and oophoritis

2.31

1.18

2.2

1.2

—

Other noninflammatory disorders of uterus, except cervix

0.00

1.18

0.0

1.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1.88

1.17

3.2

2.1

—

Diagnoses used for exclusion with ILD

2.00

1.16

1.7

2.1

—

Childhood allergy (age < 16)

149

1.50

1.15

2.9

5.0

—

Other keratitis

2.50

1.15

8.4

2.8

—

Aneurysms, operations, SAH

2.50

1.15

4.2

1.6

—

Atopic dermatitis, strict definition

202

1.45

1.15

3.4

4.0

—

Superficial injury of ankle and foot

1.85

1.13

2.8

3.9

—

Visual disturbances

183

1.48

1.12

3.3

2.9

—

Chalazion

2.33

1.12

1.9

2.8

—

Nontraumatic intracranial haemmorrhage

2.33

1.12

3.0

1.9

—

Type 2 diabetes

162

1.39

1.11

1.7

1.6

—

Parasetamol

141

1.40

1.11

4.3

2.5

—

Other and unspecified injuries of lower leg

2.26

1.10

2.1

4.2

—

COPD, hospital admissions

1.79

1.10

1.3

—

Respiratory distress of newborn

1.69

1.10

5.0

5.6

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.47

1.09

1.2

1.9

—

Conduction disorders

1.80

1.09

2.5

4.2

—

Congenital malformations of great arteries

1.78

1.09

5.1

5.4

—

Mixed conductive and sensorineural hearing loss

2.38

1.09

1.2

2.8

—

Inguinal hernia, bilateral

2.38

1.09

2.0

3.1

—

Alcohol use disorder, Swedish definition

145

1.50

1.08

1.8

—

Alcohol use disorder, ICD-based

112

1.61

1.08

1.6

1.7

—

Mixed specific developmental disorders

1.74

1.07

3.7

5.4

—

Acetic acid derivatives and related substances

0.45

1.07

3.2

2.1

—

Disorders of lipoprotein metabolism and other lipidaemias

116

1.47

1.06

1.3

1.8

—

Other chronic obstructive pulmonary disease

1.77

1.06

1.3

—

Allergic urticaria

2.12

1.05

10.3

5.5

—

Overjet

1.76

1.05

6.6

5.5

—

Epilepsy

161

1.49

1.04

2.2

3.9

—

Artrosis, including avohilmo

147

0.63

1.04

1.2

1.4

—

COPD, early/later onset

1.76

1.04

1.3

—

Visual disturbances and blindness

203

1.43

1.04

3.3

2.9

—

Hyperlipidaemia, other/unspecified

1.80

1.04

1.5

1.7

—

Heart failure and bmi 25plus

1.96

1.03

1.6

1.1

—

Mixed disorders of conduct and emotions, excluding more controls

2.28

1.03

5.6

4.2

—

Foreign body in respiratory tract

2.28

1.03

4.4

4.1

—

Disorders of continuity of bone

2.27

1.03

3.6

3.5

—

Unspecified privation

2.27

1.03

3.2

3.0

—

Amenorrhoea

2.27

1.03

2.0

3.0

—

LSIL lesion of the cervix uteri, vagina or vulva

2.27

1.03

1.2

1.5

—

Inguinal or femoral hernia, bilateral

2.27

1.03

2.0

3.0

—

Embedded teeth, including avohilmo

1.96

1.03

3.8

4.9

—

Orchitis and epididymitis

2.27

1.03

2.6

2.4

—

Coxarthrosis [arthrosis of hip](FG)

1.61

1.03

1.2

1.1

—

Spinal stenosis

0.46

1.03

1.2

1.3

—

Complications of labour and delivery

0.54

1.02

1.9

1.7

—

Fracture of lumbar spine and pelvis

2.05

1.02

2.3

2.2

—

Insulin, fast-acting

146

1.51

1.02

3.1

3.5

—

Triptan medication for migraine, min. 3 purchases

139

1.45

1.01

2.7

2.5

—

Other dorsopathies, not elsewhere classified

211

1.30

1.00

2.1

2.6

—

Alcohol dependence

1.77

1.00

1.3

1.4

—

Disorders of sclera, cornea, iris and ciliary body

180

1.44

1.00

3.7

2.2

—

Recurrent or chronic depression

1.57

0.99

1.8

1.4

—

Degenerative diseases of the nervous system

0.00

0.99

0.0

1.1

—

Use of anticholinesterases

0.00

0.99

0.0

1.2

—

N06DA Anticholinesterases

0.00

0.99

0.0

1.2

—

Abnormalities of heart beat

1.68

0.98

2.3

2.1

—

COPD related to multimorbidity

1.82

0.98

1.4

1.3

—

Migraine with aura and triptan purchases

1.84

0.98

2.6

3.0

—

Benign paroxysmal vertigo

1.84

0.98

1.0

1.7

—

Sleep disorders

238

0.69

0.98

1.8

2.3

—

Generalized anxiety disorder

1.83

0.98

2.7

2.8

—

Coronary artery bypass grafting

2.00

0.98

1.1

1.2

—

Abscess of anal and rectal regions

2.18

0.98

3.0

3.6

—

Cervical polyps

2.18

0.98

2.4

1.8

—

Injuries to unspecified part of trunk, limb or body region

1.95

0.97

3.3

4.4

—

Low back pain

178

1.36

0.96

1.3

2.1

—

Other disorders of eye and adnexa

1.80

0.96

8.4

4.2

—

Iridocyclitis

1.85

0.96

1.2

3.0

—

Fracture of femur

1.80

0.96

3.9

2.5

—

Type 2 diabetes, definitions combined

153

1.37

0.96

1.4

—

Uterine polyps

1.81

0.95

1.2

—

Soft tissue disorders

260

1.26

0.95

3.3

3.1

—

Other functional intestinal disorders

188

1.40

0.95

4.2

3.7

—

Disease of hard tissues of teeth, NOS

1.64

0.94

5.1

1.1

—

Cholecystectomy

133

1.47

0.94

1.5

1.4

—

Coxarthrosis

1.57

0.94

1.2

1.4

—

Atopic dermatitis

219

1.34

0.94

3.1

3.2

—

Conjunctivitis (acute, non atopic), including avohilmo

260

1.28

0.93

3.4

2.7

—

Use of hypnotics and sedatives

206

1.30

0.92

2.0

2.3

—

Disorders of breast

1.56

0.91

2.3

1.8

—

Spontaneous abortion

0.46

0.91

2.0

1.4

—

Insomnia

228

0.70

0.90

1.8

2.3

—

167

1.41

0.90

2.4

2.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

117

1.52

0.90

1.6

1.7

—

Type 2 diabetes, strict (exclude DM1)

155

1.35

0.90

1.4

—

Stroke, excluding SAH

1.50

0.90

2.3

1.9

—

Congenital malformations of the nervous system

2.08

0.89

3.2

5.9

—

Atrial septal defect, secundum type

1.75

0.89

4.5

5.5

—

Social phobias

2.07

0.89

3.8

3.6

—

Carpal tunnel syndrome

134

0.58

0.89

1.4

1.2

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

170

1.42

0.89

2.2

2.0

—

Type 1 diabetes, wide definition, subgroup 1

105

0.48

0.88

2.2

3.9

—

Chronic rhinitis, nasopharyngitis and pharyngitis

129

0.54

0.87

1.3

2.8

—

COPD

1.62

0.87

1.3

1.4

—

Heterophoria

1.86

0.87

5.3

5.0

—

Varicose veins

1.57

0.87

1.3

1.2

—

Foreign body entering into or through eye or natural orifice

2.00

0.87

3.3

3.2

—

Other superficial mycoses, including avohilmo

2.00

0.87

1.2

3.2

—

166

1.40

0.85

2.2

2.1

—

Eating disorder

1.82

0.85

3.0

4.0

—

Insulin, fast-acting or short human

153

1.44

0.85

3.1

3.5

—

Chronic lower respiratory diseases

296

1.23

0.84

2.6

2.9

—

Type 2 diabetes, definitions combined, including avohilmo

156

1.33

0.84

1.4

—

Haemangioma and lymphangioma, any site

1.94

0.84

3.5

3.6

—

Nasal polyp

1.78

0.84

2.5

1.3

—

Other retinal disorders

122

1.43

0.84

2.3

—

Focal epilepsy, strict definition

1.56

0.84

2.3

4.5

—

Superficial injury of head

112

0.53

0.83

4.5

3.7

—

Sulfasalazine

1.74

0.82

1.0

1.2

—

Alzheimer disease, excluding more controls

0.00

0.82

0.0

1.2

—

Congenital malformations of the respiratory system

1.88

0.82

7.7

5.6

—

Congenital malformations of the respiratory system, including avohilmo

1.88

0.82

7.7

5.6

—

Ventricular septal defect, a heart condition

1.70

0.82

7.0

5.6

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

235

1.28

0.81

2.1

2.4

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.74

0.81

1.8

1.3

—

Other nutritional deficiencies

227

1.33

0.81

2.3

2.4

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.80

0.0

5.0

—

Bacterial sepsis of newborn

1.84

0.79

4.5

6.5

—

Other infections specific to the perinatal period

0.00

0.79

0.0

6.1

—

Asthma (diagnoses ohter than nonallergic)

308

1.26

0.79

2.6

2.9

—

Other specific joint derangements/joint disorders

198

1.29

0.79

2.0

3.1

—

Early lumbar disc prolapse, operated

0.00

0.78

0.0

1.7

—

Stroke, including SAH

105

1.43

0.78

2.3

1.8

—

Psoriasis

1.62

0.78

3.6

2.0

—

Somatoform disorder

1.77

0.76

1.5

2.4

—

Other disorders of ear

247

1.26

0.76

3.2

2.7

—

Disorders of choroid and retina

163

1.33

0.76

2.1

2.2

—

Injuries to the thorax

132

1.44

0.75

1.4

2.3

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.09

0.74

10.0

7.3

—

Diseases of male genital organs

143

1.30

0.74

3.3

3.1

—

Contusion of other and unspecified parts of foot

2.09

0.74

3.8

4.3

—

Ethmoidectomy

2.08

0.74

3.4

1.8

—

Polyp of the female genital tract

1.64

0.73

2.0

1.7

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1.64

0.73

1.1

1.2

—

Other and unspecified nonorganic psychotic disorders

1.64

0.73

1.8

2.4

—

Benign lipomatous neoplasm

1.64

0.73

1.3

1.8

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.57

0.73

4.8

5.4

—

Acute nasopharyngitis (common cold)

1.83

0.73

1.0

2.0

—

Constipation

261

1.25

0.72

2.9

3.1

—

Abnormal results of function studies

2.00

0.72

2.4

5.1

—

Benign neoplasm: Rectum

2.00

0.72

1.2

—

Medical abortion

1.40

0.72

1.4

1.9

—

Lower back pain or/and sciatica

217

1.26

0.72

1.4

2.2

—

Superficial injury of forearm

1.75

0.71

5.0

4.7

—

Persistent mood disorders

1.75

0.71

1.6

2.5

—

Chronic apical periodontitis

206

1.25

0.71

1.2

2.3

—

Acne

1.61

0.70

4.5

—

Hypertrophy of breast in women and men

1.71

0.70

2.4

1.8

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.55

0.69

4.8

5.3

—

Mouth breathing

203

1.33

0.69

3.8

3.4

—

Allergic conjunctivitis

231

0.71

0.69

3.4

2.9

—

Retention of urine

1.55

0.69

1.0

1.7

—

Adverse effects, not elsewhere classified

1.51

0.69

3.1

3.8

—

Isolated growth hormone deficiency

1.69

0.69

4.7

5.9

—

Chronic suppurative otitis media, including avohilmo

1.67

0.68

3.9

5.0

—

Psoriasis vulgaris

1.67

0.68

4.4

2.5

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.67

0.68

1.1

1.8

—

Fibroblastic disorders

1.67

0.68

2.1

1.2

—

Ovarian cyst

1.60

0.68

2.9

1.7

—

Focal epilepsy

110

1.45

0.68

2.3

4.7

—

Congenital malformations of pulmonary and tricuspid valves

1.80

0.66

4.4

6.3

—

Use of pramipexole

1.79

0.66

1.2

1.3

—

Benign neoplasm: Rectum, anus and anal canal

1.79

0.66

1.2

1.1

—

Other CVD

1.79

0.66

5.0

1.9

—

Medical treatment for female infertility

1.61

0.66

2.1

1.4

—

Conductive and sensorineural hearing loss

176

1.28

0.66

3.8

2.6

—

Keratitis

111

1.44

0.65

5.2

2.4

—

Dislocation, sprain and strain of joints and ligaments at neck level

1.59

0.65

1.1

2.7

—

Cervicalgia

1.59

0.65

1.7

2.1

—

Other inflammation of eyelid, including avohilmo

180

1.33

0.64

3.3

2.7

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

137

1.39

0.64

3.1

3.6

—

Convergent concomitant strabismus

1.73

0.64

4.8

5.1

—

Superficial injury of thorax

1.72

0.64

1.2

2.3

—

Other eating disorders

1.72

0.64

3.2

4.8

—

Mental and behavioural disorders due to psychoactive substance use

181

1.32

0.63

2.2

—

Disorders of conjunctiva

305

1.22

0.63

2.5

3.1

—

Diseases of inner ear

115

1.41

0.63

1.2

1.5

—

Malignant neoplasm of prostate

1.74

0.63

1.0

1.1

—

Gastro-oesophageal reflux disease

189

1.29

0.63

2.3

2.6

—

Appendectomy

197

1.30

0.63

1.4

2.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.44

0.62

1.9

1.6

—

Acne vulgaris

1.63

0.62

4.8

4.3

—

Cerebrovascular diseases

137

1.32

0.61

2.7

1.9

—

Tumor necrosis factor alpha inhibitors

1.59

0.61

1.5

4.1

—

Mixed disorders of conduct and emotions

1.67

0.61

5.6

6.1

—

Helminthiases, including avohilmo

1.67

0.61

1.0

4.6

—

Other congenital malformations of tongue, mouth and pharynx

1.66

0.61

4.2

5.9

—

Open wound of lower leg

1.60

0.61

3.0

4.2

—

Other and unspecified effects of external causes

130

1.38

0.61

2.6

3.6

—

Inflammatory diseases of female pelvic organs

106

1.36

0.60

3.5

1.7

—

Parkinson's disease

0.00

0.60

0.0

1.6

—

Parkinson's disease, including avohilmo

0.00

0.60

0.0

1.6

—

Parkinson's disease, excluding more controls

0.00

0.60

0.0

1.7

—

Intracranial injury

259

0.75

0.60

3.6

3.0

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.60

0.0

5.4

—

Alzheimer disease

0.00

0.59

0.0

1.2

—

Metatarsalgia

0.00

0.59

0.0

2.8

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.59

0.0

2.8

—

Early lumbar disc prolapse operation

0.00

0.59

0.0

1.8

—

Car occupant injured in other and unspecified transport accidents

1.54

0.59

1.3

3.1

—

Substance use, excluding alcohol

1.54

0.59

1.0

2.0

—

Episodal and paroxysmal disorders

275

1.18

0.58

2.8

3.1

—

malignant neoplasm of male genital organs, including Hilmo

1.72

0.58

1.0

1.2

—

Juvenile arthritis (FINNGEN)

1.72

0.57

3.2

6.3

—

Mental retardation, excluding more controls

1.49

0.57

4.8

5.0

—

Voice disturbances

1.48

0.57

3.1

2.2

—

Endometriosis ASRM stages 3,4

1.67

0.56

1.5

—

Other joint disorders

212

1.20

0.56

2.0

3.3

—

Functional dyspepsia

1.45

0.56

1.3

1.8

—

Assault

1.62

0.55

2.3

2.8

—

Other inflammation of eyelid

1.62

0.55

8.7

3.1

—

Burns and corrosions

1.54

0.55

1.7

4.6

—

Substance abuse

180

1.29

0.55

2.2

—

Allergic colitis

1.54

0.55

3.9

5.0

—

External causes of morbidity and mortality

145

1.24

0.55

3.7

2.9

—

Temporomandibular joint disorders, including avohilmo

137

1.34

0.55

1.7

2.4

—

Other juvenile arthritis

1.58

0.54

3.2

5.9

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

123

1.36

0.53

2.2

3.0

—

Conjunctivitis

295

1.20

0.53

2.6

3.1

—

Myocardial infarction, without ST-elevation

1.45

0.53

1.0

1.1

—

Diabetic retinopathy, excluding more controls

1.44

0.53

2.6

1.9

—

Transport accidents

155

1.29

0.52

1.9

2.4

—

Glucosamine medication

1.44

0.52

1.1

—

Open wound of wrist and hand

186

0.73

0.52

2.1

2.5

—

Myalgia

1.43

0.52

1.6

1.9

—

Mental and behavioural disorders due to alcohol

153

1.31

0.51

2.5

2.2

—

Injury of muscle and tendon at lower leg level

1.50

0.51

1.2

2.5

—

Gonarthrosis,primary

137

0.75

0.51

1.1

1.3

—

Sleep disorders (combined)

246

0.83

0.51

1.7

2.7

—

Subjective visual disturbances

1.41

0.51

2.3

2.8

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

194

1.27

0.51

3.6

3.1

—

Other diseases of upper respiratory tract

253

1.17

0.51

3.7

2.7

—

Other/unspecified dorsalgia

1.40

0.51

3.1

2.3

—

HSIL lesion of the cervix uteri, vagina or vulva

1.46

0.50

2.2

1.3

—

Spondylopathies

127

0.74

0.50

1.3

1.9

—

Gonarthrosis

0.70

0.49

1.1

1.3

—

In situ neoplasms

1.49

0.49

1.7

1.3

—

Scabies, including avohilmo

1.43

0.49

4.5

4.0

—

Intracranial trauma

197

0.79

0.49

3.3

3.1

—

Infections specific to the perinatal period

1.53

0.48

4.4

6.1

—

Ischaemic Stroke, excluding all haemorrhages

1.35

0.47

2.0

1.8

—

Unstable angina pectoris

1.49

0.47

1.0

1.2

—

Leiomyoma of uterus

1.38

0.47

1.3

—

Postmenopausal bleeding

1.47

0.47

1.0

1.2

—

Irritable bowel syndrome

1.47

0.47

1.7

2.5

—

False labour

0.57

0.46

1.6

2.1

—

Maternal care for other conditions predominantly related to pregnancy

1.45

0.46

1.4

1.6

—

Papulosquamous disorders

111

1.35

0.46

3.1

2.0

—

Superficial injury of abdomen, lower back and pelvis

1.43

0.46

2.6

4.0

—

Thyrotoxicosis

1.40

0.45

1.4

2.0

—

Sensorineural hearing loss

157

1.23

0.45

3.1

2.6

—

Other maternal disorders predominantly related to pregnancy

0.72

0.44

1.8

1.6

—

Spondylosis

102

0.69

0.43

1.2

1.4

—

Pollen allergy

172

0.74

0.43

1.8

4.3

—

Pediculosis, acariasis and other infestations, including avohilmo

1.37

0.43

4.2

3.7

—

Redundant prepuce, phimosis and paraphimosis

1.39

0.43

4.4

2.5

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

210

1.19

0.43

2.9

2.5

—

Triptan medication for migraine, single purchase ok

210

1.19

0.43

2.9

2.5

—

Depression or dysthymia

114

1.25

0.43

3.1

1.9

—

Endometriosis of ovary

1.62

0.43

1.4

1.3

—

Sciatica+with lumbago

123

1.30

0.43

1.3

1.4

—

Alzheimer’s disease (Late onset), excluding more controls

0.00

0.42

0.0

1.2

—

Effects of foreign body entering through natural orifice

113

1.33

0.42

3.4

—

Malignant neoplasm of prostate, including Hilmo

1.55

0.42

1.0

1.1

—

Deviated nasal septum

0.65

0.42

1.2

1.5

—

Maternal care for known or suspected malpresentation of fetus

1.55

0.42

1.0

1.4

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

108

1.29

0.42

2.6

1.4

—

Other respiratory conditions originating in the perinatal period

0.00

0.42

0.0

5.4

—

Use of memantine

0.00

0.42

0.0

1.1

—

Use of other anti-dementia drugs

0.00

0.42

0.0

1.1

—

Calculus of kidney and ureter

1.43

0.41

2.2

2.0

—

Parkinson's disease, strict definition, excluding more controls

0.00

0.41

0.0

1.2

—

Impacted cerumen

1.52

0.41

6.2

4.2

—

Injury of muscle and tendon at wrist and hand level

1.52

0.41

1.0

2.4

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

0.00

0.41

0.0

5.3

—

Other and unspecified injuries of wrist and hand

0.00

0.41

0.0

5.7

—

Colon adenocarcinoma, helper endpoint

0.00

0.41

0.0

1.2

—

Stenosis and insufficiency of lacrimal passages

0.00

0.40

0.0

3.4

—

Cervicocranial syndrome

0.00

0.40

0.0

1.9

—

Use of levodopa decarboxylase inhibitor

0.00

0.40

0.0

1.7

—

Necrosis of pulp, including avohilmo

214

0.78

0.40

1.5

2.1

—

Mild mental retardation

1.47

0.40

4.8

6.5

—

Other sexually transmitted chlamydial diseases, including avohilmo

1.47

0.40

3.2

2.6

—

Alzheimer’s disease, strict definition

0.00

0.40

0.0

1.2

—

Parkinson's disease, strict definition

0.00

0.40

0.0

1.2

—

Dislocation, sprain and strain of joints and ligaments of knee

205

0.79

0.39

2.6

2.1

—

Enthesopathies of lower limb, excluding foot

1.31

0.39

1.4

2.0

—

malignant neoplasm of male genital organs

1.43

0.39

1.0

1.2

—

Dislocation, sprain and strain of joints and ligaments of elbow

1.43

0.39

2.4

4.5

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1.41

0.39

1.9

1.6

—

Kela-code for severe mental illness

104

0.67

0.39

2.3

1.6

—

Fracture of rib(s), sternum and thoracic spine

1.41

0.39

1.7

1.8

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.39

0.0

6.1

—

Disorders of muscles

0.00

0.39

0.0

3.1

—

Abnormal involuntary movements

1.39

0.38

1.2

3.5

—

Hypertrophy of breast

1.39

0.38

3.0

1.8

—

Nonorganic sleeping disorders, excluding more controls

1.34

0.38

2.7

2.2

—

Non-selective monoamine reuptake inhibitors

1.31

0.37

1.1

1.2

—

HSIL lesion of the cervix uteri

1.35

0.37

2.4

1.4

—

Pre-eclampsia

1.35

0.37

1.2

1.4

—

Type 1 diabetes, wide definition

114

0.70

0.37

3.5

4.1

—

Unspecified fall

239

1.19

0.36

4.0

3.2

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

135

0.74

0.36

2.5

3.2

—

Personality disorders, excluding more controls

1.26

0.36

1.8

1.5

—

Panic disorder

1.43

0.35

2.2

2.3

—

Obesity due to excess calories

179

0.78

0.35

1.5

2.6

—

Corneal ulcer

1.40

0.35

3.0

2.6

—

Hypertensive heart and/or renal disease

1.37

0.34

6.0

1.7

—

Dysplasia of cervi uteri

1.36

0.34

2.2

1.3

—

Obesity and other hyperalimentation

219

0.82

0.34

1.4

2.4

—

Non-allergic asthma

1.36

0.34

4.2

5.1

—

Obesity

219

0.82

0.34

1.4

2.4

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.36

0.34

1.4

1.9

—

Acute appendicitis, with complications

1.33

0.33

1.5

1.9

—

Disorders of vitreous body and globe

103

1.28

0.33

1.1

1.4

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.67

0.33

5.7

5.4

—

Internal derangement of knee

108

1.28

0.33

1.6

2.4

—

Disorders of synovium and tendon

154

1.21

0.33

3.6

1.8

—

Allergic rhinitis

207

0.81

0.33

1.6

4.0

—

Fall on same level

301

1.12

0.32

2.8

2.9

—

Other menopausal disorders

1.39

0.32

1.0

1.2

—

Conotruncal defects

1.28

0.32

4.5

5.9

—

Gestational [pregnancy-induced] hypertension

1.27

0.32

1.3

1.4

—

Acne, including avohilmo

103

1.26

0.32

3.8

4.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

200

0.81

0.32

3.4

3.0

—

Fracture of shoulder and upper arm

146

1.23

0.31

2.8

3.0

—

Other obstetric conditions, not elsewhere classified

1.33

0.31

1.4

1.9

—

Sequelae of cerebrovascular disease

1.33

0.31

2.1

1.6

—

All dysplastic lesions of the cervix uteri

1.32

0.31

2.0

1.3

—

Disorders of vestibular function (Vertigo)

1.30

0.30

1.1

1.4

—

Abrasion of teeth

0.73

0.30

1.1

1.6

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

176

0.84

0.30

2.0

2.3

—

Other disorders originating in the perinatal period

1.28

0.30

3.7

5.7

—

Other chronic obstructive pulmonary disease, including avohilmo

1.26

0.29

1.3

1.4

—

Concussion

193

0.84

0.28

3.6

3.0

—

Hypothyroidism, other/unspecified

199

0.86

0.28

2.1

2.5

—

Urolithiasis

1.32

0.28

2.2

2.1

—

Gestational diabetes (for exclusion)

1.30

0.28

1.4

1.6

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

204

0.87

0.26

2.0

2.5

—

Other neurological diseases

159

1.17

0.26

2.4

2.3

—

Diseases of pulp and periapical tissues, including avohilmo

243

0.89

0.26

1.5

3.3

—

Artificial joint operation, meniscal resection

158

0.85

0.26

1.1

1.5

—

Lumbar disc prolapse

127

0.82

0.26

1.1

1.4

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

1.28

0.26

2.0

4.6

—

Specific personality disorders

1.25

0.25

1.8

2.2

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

1.25

0.25

4.2

3.7

—

Dorsopathies

233

1.11

0.25

2.4

2.9

—

Injuries to the head

315

0.90

0.25

2.4

3.0

—

Symptoms and signs involving speech and voice

1.23

0.25

3.1

2.4

—

Scissor bite

1.22

0.25

5.1

5.4

—

Injuries to the neck

1.22

0.25

1.2

2.7

—

Coxarthrosis, primary, with hip surgery

1.18

0.24

1.2

—

Disorders of vitreous body

100

1.24

0.24

1.1

1.2

—

Fall on and from stairs and steps

1.17

0.24

1.3

3.1

—

Schizophrenia or delusion, excluding more controls

1.28

0.24

1.9

1.6

—

Injuries to the shoulder and upper arm

270

0.89

0.24

2.5

2.6

—

Coxarthrosis, primary

1.22

0.23

1.1

1.2

—

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

1.35

0.23

4.2

5.5

—

Pedal cyclist injured in noncollision transport accidents

1.32

0.23

2.0

4.0

—

Bitten or struck by other mammals

1.32

0.23

2.8

4.0

—

Unspecified mental disorder

125

0.80

0.23

2.2

1.8

—

Other and unspecified disorders of psychological development

1.28

0.23

6.4

5.2

—

Spondylolisthesis/Spondylolysis

1.28

0.23

1.0

1.7

—

Pre-eclampsia or eclampsia

1.25

0.22

1.2

1.4

—

Calcific aortic valvular stenosis, operated

1.23

0.22

1.2

2.0

—

Calcific aortic valvular stenosis

1.23

0.22

1.2

2.0

—

Type 1 diabetes

125

1.20

0.22

3.7

3.8

—

Patent foramen ovale

1.22

0.22

5.2

5.4

—

Asthma, including avohilmo

304

1.09

0.22

2.5

2.9

—

Other perinatal haematological disorders

0.00

0.21

0.0

6.5

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.21

0.0

3.7

—

Craniosynostosis EXCLUDE syndromes

0.00

0.21

0.0

5.3

—

Severe mental retardation

0.00

0.21

0.0

5.5

—

Hypospadias

0.00

0.21

0.0

5.5

—

Other congenital malformations of kidney

0.00

0.21

0.0

5.3

—

Crushed, pushed or stepped on by crowd or human stampede

1.19

0.21

1.4

4.5

—

Testicular hypofunction

0.00

0.21

0.0

1.7

—

Female infertility, tubal origin

0.00

0.21

0.0

1.3

—

Nontoxic single thyroid nodule

0.00

0.21

0.0

2.0

—

Transient global amnesia

0.00

0.21

0.0

1.3

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

0.21

0.0

1.1

—

Pleural plaque

0.00

0.21

0.0

1.0

—

Primary hyperparathyroidism

0.00

0.21

0.0

1.4

—

Disorders of muscle tone of newborn

0.00

0.21

0.0

5.3

—

Other congenital malformations of ear

0.00

0.21

0.0

5.9

—

Testicular dysfunction

0.00

0.21

0.0

1.7

—

Foreign body or object entering through skin

0.00

0.21

0.0

2.2

—

Failed induction of labour

0.00

0.21

0.0

1.5

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

0.21

0.0

1.7

—

Superficial injury of lower leg

1.22

0.21

3.1

3.2

—

Use of donepezil

0.00

0.21

0.0

1.1

—

Toxic effect of contact with venomous animals

0.00

0.21

0.0

4.2

—

Injuries to the elbow and forearm

270

1.11

0.20

3.5

2.8

—

Fetus and newborn affected by maternal complications of pregnancy

1.26

0.20

5.7

5.9

—

Gonarthrosis [arthrosis of knee](FG)

0.84

0.20

1.1

—

Sequelae of injuries of lower limb

0.00

0.20

0.0

1.6

—

Alzheimer’s disease (Late onset)

0.00

0.20

0.0

1.1

—

Thyrotoxicosis, other and/or unspecified

1.25

0.20

1.5

2.4

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1.20

0.19

3.8

1.8

—

Pure hypercholesterolaemia

104

1.16

0.19

1.2

1.8

—

Behavioural syndromes associated with physiological disturbances and physical factors

275

0.91

0.19

3.0

2.6

—

Burns and corrosions of external body surface, specified by site

1.15

0.19

2.2

4.7

—

Injury, poisoning and certain other consequences of external causes

120

1.13

0.19

4.1

3.0

—

Fracture at wrist and hand level

164

0.85

0.19

2.9

2.8

—

Long labour

1.21

0.18

1.1

1.4

—

Benzodiazepine use

231

0.91

0.18

1.6

2.2

—

Supervision of normal pregnancy

1.14

0.18

1.6

2.1

—

Malignant neoplasm of breast, including Hilmo

0.74

0.17

1.2

1.1

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

0.74

0.17

1.2

1.1

—

Malignant neoplasm of breast

0.75

0.17

1.2

1.1

—

Malignant neoplasm of breast, HER2-negative

0.75

0.17

1.2

1.1

—

Other (not insulin) diabetes medications

164

0.89

0.17

1.5

—

Glaucoma suspect

1.13

0.17

3.4

1.5

—

Falls/tendency to fall

270

0.93

0.17

3.8

2.9

—

Antenatal screening

1.15

0.16

1.4

2.1

—

Degeneration of macula and posterior pole

1.16

0.16

2.6

1.2

—

Symptoms and signs involving the nervous and musculoskeletal systems

234

1.11

0.16

3.8

3.0

—

Acute alcohol intoxication

0.78

0.15

4.7

2.5

—

Diabetic retinopathy

1.14

0.15

2.6

1.7

—

Suicide or other Intentional self-harm

1.14

0.15

2.0

2.5

—

Personality disorders

1.13

0.15

1.8

2.0

—

Type 1 diabetes, definitions combined

1.20

0.15

3.5

5.1

—

Organic, including symptomatic, mental disorders

0.81

0.15

1.0

1.6

—

Nonorganic sleeping disorders

1.08

0.14

2.7

3.1

—

Other disorders of eyelid

0.80

0.14

2.3

1.7

—

Type1 diabetes, definitions combined, early onset

0.80

0.14

4.4

5.4

—

Rotator cuff syndrome

116

1.13

0.14

1.1

1.4

—

Diabetes medication

239

1.07

0.14

2.8

2.6

—

Other and unspecified disorders of vitreous body

1.19

0.14

1.1

1.2

—

Fracture of foot, except ankle

1.17

0.13

4.6

3.0

—

Poisoning by drugs, medicaments and biological substances

1.18

0.12

2.0

2.7

—

Insulin, intermediate and long-acting

185

1.09

0.11

2.7

2.9

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.15

0.10

1.3

1.4

—

Periapical abscess

177

0.90

0.10

1.4

2.6

—

Ankyloglossia

1.13

0.10

4.2

6.1

—

Alcohol abuse, main dg, excluding more controls

1.14

0.10

5.4

2.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

1.14

0.10

1.0

1.7

—

Isolated patent ductus arteriosus

1.10

0.09

5.6

5.9

—

Tinnitus

1.09

0.09

1.4

—

Hyperplasia of prostate

1.15

0.09

1.0

1.1

—

Other extrapyramidal and movement disorders in other diseases

1.06

0.09

1.0

2.1

—

Acute appendicitis, no complications

185

0.91

0.09

1.6

1.8

—

Superficial injury of wrist and hand

116

1.12

0.09

2.2

3.7

—

Pregnancy hypertension

1.15

0.09

1.3

1.5

—

Hypothyroidism, strict autoimmune

127

1.08

0.08

2.1

2.6

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.07

0.08

4.3

6.0

—

Maternal care for other known or suspected fetal problems

0.78

0.08

1.2

1.9

—

Pre-eclampsia or poor fetal growth

1.03

0.08

1.2

1.4

—

Peritonsillar abscess

0.77

0.08

1.2

2.1

—

Dermatophytosis, including avohilmo

221

0.93

0.08

2.0

2.4

—

Injuries to the hip and thigh

131

1.09

0.08

2.9

2.7

—

Congenital malformations of genital organs

0.84

0.07

4.2

5.7

—

Primary gonarthrosis, bilateral

0.89

0.07

1.1

—

Other abnormal products of conception

0.83

0.07

1.7

1.5

—

Extrapyramidal and movement disorders

0.86

0.07

1.0

2.3

—

Excessive earwax

222

0.94

0.07

3.1

2.9

—

Other arthrosis

0.90

0.07

1.2

1.3

—

Cervical disc disorders

1.06

0.07

1.1

1.4

—

Nerve, nerve root and plexus disorders

190

0.95

0.07

2.1

1.7

—

Pedal cyclist injured in transport accident

1.03

0.07

1.7

3.7

—

Mental retardation

0.87

0.06

4.8

5.9

—

Mental retardation, wide definition

0.87

0.06

4.8

5.9

—

Other external causes of accidental injury

194

0.96

0.06

3.8

3.0

—

Fall on same level involving ice and snow

203

0.94

0.06

2.8

2.3

—

Other congenital malformations, including avohilmo

100

1.10

0.05

2.9

4.8

—

Other symptoms and signs involving cognitive functions and awareness

1.08

0.04

1.2

1.8

—

Type 1 diabetes, strict (exclude DM2)

1.10

0.04

3.5

5.2

—

Fracture of forearm

207

0.95

0.04

3.5

3.0

—

Other fall from one level to another

129

0.93

0.03

4.5

3.7

—

Injuries to the knee and lower leg

285

1.02

0.03

2.9

2.8

—

Other symptoms and signs involving the nervous and musculoskeletal systems

161

1.06

0.03

4.8

3.3

—

Caries of dentine, including avohilmo

158

1.03

0.03

3.4

3.3

—

Sleep apnoea

195

1.03

0.03

1.3

2.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

103

1.07

0.03

1.6

1.3

—

Diseases of appendix

215

1.04

0.03

1.9

—

Sub-endpoint used in defining T1D endpoints

136

0.94

0.03

4.0

—

Vasomotor and allergic rhinitis

194

0.96

0.02

2.0

3.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.08

0.02

2.2

1.9

—

Dental pulpitis, including avohilmo

229

0.98

0.01

1.2

2.3

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

215

1.02

0.01

2.7

—

Deforming dorsopathies

104

1.06

0.00

2.9

3.3

—

Sleep apnoea, including avohilmo

203

0.98

0.00

1.3

2.0

—

Injuries to the wrist and hand

302

0.99

0.00

2.4

2.9

—

Fracture of lower leg, including ankle

195

1.01

0.00

3.2

2.3

—

Appendicitis, broad definition

215

1.00

0.00

1.6

1.9

—

Other spirochaetal diseases

1.05

0.00

2.1

2.4

—

Other intervertebral disc disorders

133

0.99

0.00

1.1

1.4

—

Schizophrenia, schizotypal and delusional disorders

1.05

0.00

1.9

2.2

—

Schizophrenia or delusion

1.05

0.00

1.9

2.2

—

Exposure to other specified factors

316

1.00

0.00

2.5

2.9

—

Other headache syndromes

127

1.02

0.00

3.1

2.2

—

Accidents

194

1.01

0.00

3.7

3.0

—

Gonarthrosis, primary, with knee surgery

0.98

0.00

1.2

1.1

—

Striking against or struck by other objects

194

0.98

0.00

2.2

3.4

—

Selective serotonin reuptake inhibitors

197

1.00

0.00

2.7

2.6

—

Glaucoma

0.99

0.00

2.5

1.5

—

Acute appendicitis

210

1.02

0.00

1.6

1.9

—

Pregnancy with abortive outcome

0.98

0.00

1.4

1.9

—

Disorders of the thyroid gland

218

1.01

0.00

1.9

2.4

—

Shoulder lesions

126

1.00

0.00

1.1

1.5

—

Arthrosis

101

0.98

0.00

1.2

1.4

—

Diabetes, insulin treatment (Kela reimbursement)

233

1.00

0.00

2.6

—

D07AA Corticosteroids, weak (group I)

117

1.02

0.00

4.1

—

Asthma/COPD (KELA code 203)

291

1.01

0.00

2.6

2.9

—

Open wound of head

244

1.00

0.00

2.4

3.2

—

Other spirochaetal diseases, including avohilmo

1.02

0.00

2.1

2.4

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.03

0.00

1.9

2.3

—

Obesity related asthma

103

0.97

0.00

1.3

2.3

—

Diabetes mellitus in pregnancy

1.02

0.00

1.6

1.9

—

Meniscus derangement

1.01

0.00

1.5

1.4

—

Olecranon bursitis

0.00

0.0

1.0

—

Congenital malformations of eye, ear, face and neck

0.94

0.00

4.8

5.9

—

Congenital malformations of oesophagus, including avohilmo

0.00

0.0

5.2

—

Glaucoma, exfoliation

0.00

0.0

1.1

—

Microcephaly

0.00

0.0

6.0

—

Supervision of high-risk pregnancy

0.88

0.00

1.6

2.0

—

Other acquired deformities of musculoskeletal system and connective tissue

0.00

0.0

3.0

—

Papillary adenocarcinoma of thyroid gland

0.00

0.0

2.0

—

Congenital malformations of lung, including avohilmo

0.00

0.0

4.8

—

Down's syndrome

0.00

0.0

4.8

—

Gonococcal infection

0.00

0.0

3.2

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

0.0

1.3

—

Other secondary gonarthrosis

0.00

0.0

1.3

—

Iridocyclitis in diseases classified elsewhere

0.00

0.0

7.0

—

Maternal care for known or suspected disproportion

0.00

0.0

1.7

—

Communicating hydrocephalus

0.00

0.0

4.5

—

Burn and corrosion of hip and lower limb, except ankle and foot

0.00

0.0

4.4

—

Congenital malformations of oesophagus

0.00

0.0

5.2

—

Lyme disease

0.99

0.00

2.2

2.3

—

Other and unspecified intracranial injuries

0.00

0.0

2.0

—

Other osteochondrodysplasias, including avohilmo

0.00

0.0

5.0

—

Lyme disease, including avohilmo

0.99

0.00

2.2

2.3

—

Alcohol abuse, main dg

1.02

0.00

5.4

3.3

—

Unspecified visual impairment (binocular)

0.00

-0.00

0.0

5.6

—

Gender identity disorders

0.00

-0.00

0.0

6.8

—

Medial epicondylitis

0.00

-0.00

0.0

1.2

—

Dementia in Alzheimer disease

0.00

-0.00

0.0

1.0

—

Subacute thyroiditis

0.00

-0.00

0.0

3.8

—

Obesity, other/unspecified

0.96

-0.00

1.2

2.0

—

Other specified and unspecified strabismus

0.00

-0.00

0.0

3.9

—

Dermatitis due to ingested food

0.92

-0.00

4.1

5.2

—

Ganglion

0.98

-0.00

3.6

1.7

—

Gluteal tendinitis

0.00

-0.00

0.0

1.6

—

Left bundle-branch block

0.00

-0.00

0.0

1.0

—

Endometriosis

0.99

-0.00

1.1

1.8

—

Gonococcal infection, including avohilmo

0.00

-0.00

0.0

3.6

—

Café au lait spots

0.00

-0.00

0.0

5.3

—

Convulsions of newborn

0.00

-0.00

0.0

5.2

—

Lymphangioma, anys site

0.00

-0.00

0.0

5.3

—

Muscle strain

0.00

-0.00

0.0

3.5

—

Prepatellar bursitis

0.00

-0.00

0.0

2.5

—

Other surgical follow-up care

0.00

-0.00

0.0

6.0

—

Torticollis

0.00

-0.00

0.0

7.4

—

Unspecified event, undetermined intent

0.00

-0.00

0.0

4.9

—

Unspecified threat to breathing

0.00

-0.00

0.0

5.8

—

Inhalation and ingestion of food causing obstruction of respiratory tract

0.00

-0.00

0.0

5.2

—

Contact with venomous snakes and lizards

0.00

-0.00

0.0

5.2

—

Contact with other hot metals

0.00

-0.00

0.0

5.2

—

Hereditary retinal dystrophy

0.00

-0.00

0.0

5.4

—

Poisoning by medicine

0.89

-0.00

1.4

2.8

—

Transient ischemic attack

0.93

-0.00

1.6

1.3

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

0.00

-0.00

0.0

4.3

—

Contusion of toe(s) without damage to nail

0.00

-0.00

0.0

4.9

—

Injury of eye and orbit

0.98

-0.00

2.4

3.3

—

Traumatic amputation of wrist and hand

0.00

-0.00

0.0

3.4

—

Other abnormal immunological findings in serum

0.00

-0.00

0.0

8.1

—

L02BX Other hormone antagonists and related agents

0.00

-0.00

0.0

1.0

—

Pectus excavatum

0.00

-0.00

0.0

7.4

—

Calcific tendinitis of shoulder

0.00

-0.00

0.0

1.1

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

5.6

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

3.6

—

Infliximab

0.00

-0.00

0.0

3.8

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.95

-0.00

1.1

1.4

—

Disturbances of smell and taste

0.00

-0.00

0.0

1.4

—

Faecal incontinence

0.00

-0.00

0.0

1.2

—

Reduction defects of upper limb

0.00

-0.00

0.0

4.7

—

Other osteochondrodysplasias

0.00

-0.00

0.0

5.0

—

Congenital malformations of lung

0.00

-0.00

0.0

4.8

—

Hypospadias with an incomplete glans penis

0.00

-0.00

0.0

6.2

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

0.91

-0.00

5.8

3.9

—

Congenital lens malformations

0.00

-0.00

0.0

6.0

—

Acute alcohol intoxication, ICD10

0.88

-0.00

4.7

2.6

—

Alcohol-induced chronic pancreatitis

0.00

-0.00

0.0

1.0

—

Congenital cataract

0.00

-0.00

0.0

6.0

—

Noonan syndrome

0.00

-0.00

0.0

4.8

—

Muscular dystrophy

0.00

-0.00

0.0

7.3

—

Reduction defects of upper limb, including avohilmo

0.00

-0.00

0.0

4.7

—

Osteogenesis imperfecta

0.00

-0.00

0.0

6.0

—

Congenital ptosis

0.00

-0.00

0.0

6.0

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

-0.00

0.0

7.2

—

Microtia (small ears)

0.00

-0.00

0.0

6.8

—

Mastocytosis

0.00

-0.00

0.0

5.3

—

Cleft hard palate NOS

0.00

-0.00

0.0

6.4

—

Congenital ptosis, including avohilmo

0.00

-0.00

0.0

6.0

—

Birth injury to skeleton

0.00

-0.00

0.0

7.0

—

Other congenital malformations

0.91

-0.00

3.4

5.1

—

Pectus excavatum, including avohilmo

0.00

-0.00

0.0

7.9

—

Artificial joint re-operation

0.00

-0.00

0.0

1.3

—

Prominent ears

0.00

-0.00

0.0

5.6

—

Tuberous sclerosis 1

0.00

-0.00

0.0

3.8

—

Maternal care for known or suspected abnormality of pelvic organs

0.89

-0.00

1.0

1.9

—

Congenital malformations of ear causing impairment of hearing

0.00

-0.00

0.0

7.2

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.5

—

Neuralgia and neuritis, unspecified

0.00

-0.00

0.0

1.0

—

Preterm labour and delivery

0.86

-0.00

1.6

1.3

—

Malignant neoplasm of bladder, including Hilmo

0.00

-0.00

0.0

2.7

—

Colon adenocarcinoma

0.00

-0.00

0.0

1.2

—

Arterial embolism and thrombosis of lower extremity artery

0.00

-0.00

0.0

4.0

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

-0.00

0.0

1.3

—

Noise effects on inner ear

0.00

-0.00

0.0

1.0

—

Disorder of visual pathways, unspecified

0.00

-0.00

0.0

8.2

—

Ankylosing spondylitis, strict definition

0.00

-0.00

0.0

1.8

—

Glucagon-like peptide-1 (GLP-1) analogues

0.95

-0.00

1.1

1.4

—

Other demyelinating diseases of the central nervous system

0.00

-0.00

0.0

3.8

—

Lesion of plantar nerve

0.00

-0.00

0.0

1.3

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

-0.00

0.0

2.8

—

Cluster headache, strict, including avohilmo

0.00

-0.00

0.0

3.2

—

Benign neoplasm: Adrenal gland

0.00

-0.00

0.0

1.3

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

-0.00

0.0

3.0

—

Cluster headache, strict

0.00

-0.00

0.0

1.7

—

Other disorders of central nervous system

0.00

-0.00

0.0

6.0

—

Mental and behavioural disorders due to cannabinoids

0.00

-0.00

0.0

2.4

—

Disorders of adult personality and behaviour

0.94

-0.00

1.8

2.3

—

Cluster headache, wide

0.00

-0.00

0.0

1.7

—

Cluster headache, wide,, including avohilmo

0.00

-0.00

0.0

3.2

—

Immunodeficiency associated with other major defects

0.00

-0.00

0.0

3.2

—

Congenital hypothyroidism without goiter

0.00

-0.00

0.0

6.2

—

Benign neoplasm of other and unspecified female genital organs

0.00

-0.00

0.0

2.6

—

Digeorge syndrome

0.00

-0.00

0.0

3.2

—

Cardiodefibrillation

0.96

-0.00

1.2

1.5

—

Spirochaetal infections, other/unspecified, including avohilmo

0.96

-0.00

2.2

2.3

—

Use of rivastigmine

0.00

-0.00

0.0

1.0

—

Amoebiasis, including avohilmo

0.00

-0.00

0.0

3.8

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS